BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//171.67.215.200//NONSGML kigkonsult.se iCalcreator 2.26.9//
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-FROM-URL:http://web.stanford.edu/group/radweb/cgi-bin/radcalendar
X-WR-TIMEZONE:America/Los_Angeles
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
X-LIC-LOCATION:America/Los_Angeles
BEGIN:STANDARD
DTSTART:20231105T020000
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
RDATE:20241103T020000
TZNAME:PST
END:STANDARD
BEGIN:DAYLIGHT
DTSTART:20240310T020000
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
RDATE:20250309T020000
TZNAME:PDT
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
UID:ai1ec-2487@web.stanford.edu/group/radweb/cgi-bin/radcalendar
DTSTAMP:20240410T061457Z
CATEGORIES;LANGUAGE=en-US:Annual Conferences\,Radiology
CONTACT:Ashley Williams\; ashleylw@stanford.edu\; https://fimh2021.github.i
o/
DESCRIPTION:Join us for the 11th biennial International Conference on Funct
ional Imaging and Modeling of the Heart (FIMH). FIMH-2021 will celebrate 2
0 years of bringing together friends\, colleagues\, and collaborators to s
hare and discuss the latest in cardiac and cardiovascular imaging\, electr
ophysiology\, computational modeling\, and translational applications. The
event will take place June 21-25\, 2021 virtually\, via Livestream\, Zoom
meeting workshops\, and Spatial Chat networking.\n \nSponsored by: Functi
onal Imaging and Modeling of the Heart Conference\nTickets: https://www.ev
entbrite.com/e/fimh-2021-registration-142940529973?aff=RadiologyExternalCa
lendar.
DTSTART;VALUE=DATE:20210621
DTEND;VALUE=DATE:20210626
LOCATION:Virtual Event
SEQUENCE:0
SUMMARY:International Conference on Functional Imaging and Modeling of the
Heart
URL:http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/event/internat
ional-conference-on-functional-imaging-and-modeling-of-the-heart/
X-COST-TYPE:external
X-WP-IMAGES-URL:thumbnail\;http://web.stanford.edu/group/radweb/cgi-bin/rad
calendar/wp-content/uploads/2019/10/FIMH_sidebar_logo-150x150.jpg\;150\;15
0\;1\,medium\;http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/wp-
content/uploads/2019/10/FIMH_sidebar_logo.jpg\;300\;300\;
X-ALT-DESC;FMTTYPE=text/html:\\n\\n
\\n\\n\\nJoin us for the 11th b
iennial International Conference on Functional Imaging and Modeling of the
Heart (FIMH). FIMH-2021 will celebrate 20 years of bringing together
friends\, colleagues\, and collaborators to share and discuss the latest i
n cardiac and cardiovascular imaging\, electrophysiology\, computational m
odeling\, and translational applications. The event will take place June 2
1-25\, 2021 virtually\, via Livestream\, Zoom meeting workshops\, and Spat
ial Chat networking.
\n
\nSponsored by: Functional Imaging and Modeling of the Heart C
onference
\nTickets: https://www.eventbrite.com/e/fimh-2021-registration
-142940529973?aff=RadiologyExternalCalendar.
X-TICKETS-URL:https://www.eventbrite.com/e/fimh-2021-registration-142940529
973?aff=RadiologyExternalCalendar
END:VEVENT
BEGIN:VEVENT
UID:ai1ec-2677@web.stanford.edu/group/radweb/cgi-bin/radcalendar
DTSTAMP:20240410T061457Z
CATEGORIES;LANGUAGE=en-US:Canary Center
CONTACT:Ashley Williams\; ashleylw@stanford.edu\; https://www.earlydetectio
nresearch.com/
DESCRIPTION:Cancer Research UK\, OHSU Knight Cancer Institute and the Canar
y Center at Stanford\, present the Early Detection of Cancer Conference se
ries. The annual Conference brings together experts in early detection fro
m multiple disciplines to share ground breaking research and progress in t
he field.\nThe Conference is part of a long-term commitment to invest in e
arly detection research\, to understand the biology behind early stage can
cers\, find new detection and screening methods\, and enhance uptake and a
ccuracy of screening.\nThe 2021 conference will take place October 6-8 vir
tually. For more information visit the website: http://earlydetectionresea
rch.com/\nTickets: https://www.earlydetectionresearch.com/virtual-experien
ce/.
DTSTART;VALUE=DATE:20211006
DTEND;VALUE=DATE:20211009
LOCATION:Virtual Event
SEQUENCE:0
SUMMARY:Early Detection of Cancer Conference
URL:http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/event/early-de
tection-of-cancer-conference-2/
X-COST-TYPE:external
X-WP-IMAGES-URL:thumbnail\;http://web.stanford.edu/group/radweb/cgi-bin/rad
calendar/wp-content/uploads/2019/10/EDx21_300x300-150x150.jpg\;150\;150\;1
\,medium\;http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/wp-cont
ent/uploads/2019/10/EDx21_300x300.jpg\;300\;300\;
X-ALT-DESC;FMTTYPE=text/html:\\n\\n\\n\\n\\nCancer Research UK\, OHSU Knight Cancer
Institute and the Canary Center at Stanford\, present the Early Detection
of Cancer Conference series. The annual Conference brings together experts
in early detection from multiple disciplines to share ground breaking res
earch and progress in the field.
\nThe Conference is part of a long-
term commitment to invest in early detection research\, to understand the
biology behind early stage cancers\, find new detection and screening meth
ods\, and enhance uptake and accuracy of screening.
\nThe 20
21 conference will take place October 6-8 virtually. For
more information visit the website: http://earlydetectionresearch.com/
\nTickets: https://www.earlydetectionresearch.com/virtual-
experience/.
X-TICKETS-URL:https://www.earlydetectionresearch.com/virtual-experience/
END:VEVENT
BEGIN:VEVENT
UID:ai1ec-2363@web.stanford.edu/group/radweb/cgi-bin/radcalendar
DTSTAMP:20240410T061457Z
CATEGORIES;LANGUAGE=en-US:Radiology
CONTACT:
DESCRIPTION:Radiology Department-Wide Research Meeting\n• Research Announce
ments\n• Michelle James\, PhD – Detecting and Tracking Immune Responses in
the Brain and Beyond using PET\n• Ryan Spitler\, PhD – Precision Health a
nd Integrated Diagnostics (PHIND) Center\nLocation: Zoom – Details can be
found here: https://radresearch.stanford.edu\nMeetings will be the 3rd Fri
day of each month.\n \nHosted by: Brian Hargreaves\, PhD\nSponsored by: th
e the Department of Radiology
DTSTART;TZID=America/Los_Angeles:20210416T120000
DTEND;TZID=America/Los_Angeles:20210416T130000
SEQUENCE:0
SUMMARY:Radiology-Wide Research Meeting
URL:http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/event/radiolog
y-wide-research-meeting-4/
X-COST-TYPE:free
X-WP-IMAGES-URL:thumbnail\;http://web.stanford.edu/group/radweb/cgi-bin/rad
calendar/wp-content/uploads/2021/03/research-meeting-150x150.png\;150\;150
\;1\,medium\;http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/wp-c
ontent/uploads/2021/03/research-meeting-300x133.png\;300\;133\;1\,large\;h
ttp://web.stanford.edu/group/radweb/cgi-bin/radcalendar/wp-content/uploads
/2021/03/research-meeting.png\;628\;278\;
X-ALT-DESC;FMTTYPE=text/html:\\n\\n\\n\\n\\nRadiology Department-
Wide Research Meeting
\n• Research Announcements
\n• M
ichelle James\, PhD – Detecting and Tracking Immune Responses in the Brain
and Beyond using PET
\n• Ryan Spitler\, PhD – Precision Health and I
ntegrated Diagnostics (PHIND) Center
\nLocation: Zo
om – Details can be found here: https://radresearch.stanford.edu
\nMeetings will be the 3rd Frid
ay of each month.
\n
\nHosted by: Brian Hargreaves\, PhD<
/em>
\nSponsored by: the the Department of Radiology
\n
BODY>
END:VEVENT
BEGIN:VEVENT
UID:ai1ec-1509@web.stanford.edu/group/radweb/cgi-bin/radcalendar
DTSTAMP:20240410T061457Z
CATEGORIES;LANGUAGE=en-US:PHIND\,PHIND Seminar Series
CONTACT:Ashley Williams\; ashleylw@stanford.edu
DESCRIPTION:PHIND Seminar Series: Impact of the Veterans Affairs National A
bdominal Aortic Screening Program\nManuel Garcia-Toca\, M.D.\nClinical Pro
fessor of Surgery\nChief\, Division of Vascular Surgery\nSanta Clara Vall
ey Medical Center (SCVMC)\n \nOliver O. Aalami\, M.D.\nClinical Associate
Professor of Surgery\, Vascular Surgery\nLucile Packard Children’s Hospita
l\n \nLocation: Zoom\nWebinar URL: https://stanford.zoom.us/s/98417624095
\nDial: US: +1 650 724 9799 or +1 833 302 1536 (Toll Free)\nWebinar ID: 9
84 1762 4095\nPasscode: 111283\n11:00am – 12:00pm Seminar & Discussion\nRS
VP Here\n \nABSTRACT\nBackground: The U.S. Federal Government enacted the
Screen for Abdominal Aortic Aneurysms Very Efficiently Act in January 2007
. Simultaneously\, the Department of Veterans Affairs (VA) implemented a m
ore inclusive AAA screening policy for veteran beneficiaries shortly after
wards.\n \nOur study aimed to evaluate the impact of the VA program on AAA
detection rate and all-cause mortality compared to a cohort of patients w
hose aneurysms were identified by other abdominal imaging.\n \nMethods: We
identified veterans with an AAA screening study using the two existing Cu
rrent Procedural Terminology (CPT) codes (G0389 and 76706). In the compar
ison group\, eligible abdominal imaging studies included ultrasound\, comp
uted tomography (CT)\, and magnetic resonance imaging (MRI) queried accord
ing to CPT codes between 2001 and 2018.\n \nWe used a difference-in-differ
ences regression model to evaluate the change in aneurysm detection rate a
nd all-cause mortality five years before and eleven years after the VA imp
lemented the screening policy in 2007.\n \nWe calculated survival estimate
s after AAA screening or non-screening imaging of patients with or without
AAA diagnosis and used multivariate Cox regression model to evaluate mort
ality in patients with a positive AAA diagnosis adjusting for patient char
acteristics and comorbidities.\n \nResults: We identified 3.9 million vete
rans with abdominal imaging\, a total of 303\,664 of whom were coded has h
aving an AAA US screening between 2007 and 2018. An AAA diagnosis was made
in 4.84% of the screening group vs. 1.3% in the non-screening imaging gro
up P
DTSTART;TZID=America/Los_Angeles:20210420T110000
DTEND;TZID=America/Los_Angeles:20210420T120000
LOCATION:Zoom - See Description for Zoom Link
SEQUENCE:0
SUMMARY:PHIND Seminar – Manuel Garcia-Toca\, M.D. & Oliver O. Aalami\, M.D.
URL:http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/event/phind-se
minar-manuel-garcia-toca-m-d-oliver-o-aalami-m-d/
X-COST-TYPE:external
X-WP-IMAGES-URL:thumbnail\;http://web.stanford.edu/group/radweb/cgi-bin/rad
calendar/wp-content/uploads/2019/10/2020.4_SpeakerMashUp_V2-01-150x150.png
\;150\;150\;1\,medium\;http://web.stanford.edu/group/radweb/cgi-bin/radcal
endar/wp-content/uploads/2019/10/2020.4_SpeakerMashUp_V2-01-300x150.png\;3
00\;150\;1\,large\;http://web.stanford.edu/group/radweb/cgi-bin/radcalenda
r/wp-content/uploads/2019/10/2020.4_SpeakerMashUp_V2-01-1024x513.png\;640\
;321\;1\,full\;http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/wp
-content/uploads/2019/10/2020.4_SpeakerMashUp_V2-01.png\;1050\;526\;
X-ALT-DESC;FMTTYPE=text/html:\\n\\n\\n\\n\\nPHIND Seminar Serie
s: Impact of the Veterans Affairs National Abdominal Aortic Screening
Program
\nManuel Garcia-Toca\, M.D.
\nClinical Profe
ssor of Surgery
\nChief\, Division of Vascular Surgery
\nSanta
Clara Valley Medical Center (SCVMC)
\n
\nOliver O. Aalami\, M.D.
\nClinical Associate Professor of Surgery\, Vascular Surgery
\nLucile Packard Children’s Hospital
\n
\nLocation: Zoom
\nWebinar URL: https://stanford.zoom.us/s/98417624095
\nDi
al: US: +1 650 724 9799 or +1 833 302 1536 (Toll Free)
\nWebinar ID:
984 1762 4095
\nPasscode: 111283
\n11:00am – 12:00pm Seminar &
Discussion
\nRSVP Here
\n
\nABSTRACT
\nBackground: The U.S. Federal
Government enacted the Screen for Abdominal Aortic Aneurysms Very Efficie
ntly Act in January 2007. Simultaneously\, the Department of Veterans Affa
irs (VA) implemented a more inclusive AAA screening policy for veteran ben
eficiaries shortly afterwards.
\n
\nOur study aimed to evalua
te the impact of the VA program on AAA detection rate and all-cause mortal
ity compared to a cohort of patients whose aneurysms were identified by ot
her abdominal imaging.
\n
\nMethods: We iden
tified veterans with an AAA screening study using the two existing Cur
rent Procedural Terminology (CPT) codes (G0389 and 76706). In the co
mparison group\, eligible abdominal imaging studies included ultrasound\,
computed tomography (CT)\, and magnetic resonance imaging (MRI) queried ac
cording to CPT codes between 2001 and 2018.
\n
\nWe used a di
fference-in-differences regression model to evaluate the change in aneurys
m detection rate and all-cause mortality five years before and eleven year
s after the VA implemented the screening policy in 2007.
\n
\nWe calculated survival estimates after AAA screening or non-screening ima
ging of patients with or without AAA diagnosis and used multivariate Cox r
egression model to evaluate mortality in patients with a positive AAA diag
nosis adjusting for patient characteristics and comorbidities.
\n
p>\n
Results: We identified 3.9 million veterans with a
bdominal imaging\, a total of 303\,664 of whom were coded has having an AA
A US screening between 2007 and 2018. An AAA diagnosis was made in 4.84% o
f the screening group vs. 1.3% in the non-screening imaging group P<0.001\, yet more aneurysms were found with general imaging studies (50\
,730 vs.15\,449) (Fig 1).
\n
\nOn Kaplan-Meier survival analy
sis\, patients with an AAA diagnosis had higher overall mortality than pat
ients who screened normal\; patients with aneurysms found with non-screeni
ng imaging had the highest mortality\, log-rank P<0.001 (Fig 2).<
/p>\n
\nThe difference in differences regression analysis\, show
ed that the absolute AAA detection rate was 1.55% higher (95% CI 1.2- 1.8)
\, and the mortality was 13.89 % lower (95% CI 10.18 %-16.66 %) after the
introduction of the screening program in 2007.
\n
\nMultivari
ate Cox regression analysis in patients with AAA diagnosis (65-74-year-old
) demonstrated a significantly lower 5-year mortality [HR 0.45 (95% CI 0.4
3-0.48)] for patients in the US Screening group P<0.001.
\n
\nConclusions: In a nationwide a
nalysis of VA patients\, implementation of AAA screening was associated wi
th improved survival and a higher rate of AAA diagnosis. These findings pr
ovide further support for this program’s continuation versus defaulting to
incidental recognition following other abdominal imaging.
\n
\n
ABOUT MANUEL GARCIA-TOCA
\nDr. Garcia-Toca earned
his medical degree at the Universidad Anahuac in Mexico 1999. He has a ma
ster’s degree in Health Policy from Stanford University.
\n
\nHe received his general surgery training at the Massachusetts General Hos
pital and Brown University in 2008. He then completed a Vascular Surgery f
ellowship at Northwestern University in 2010. Dr. Garcia-Toca is board cer
tified in both surgery and vascular surgery.
\n
\nDr. Garcia-
Toca joined Stanford Vascular Surgery in 2015. He is currently Clinical Pr
ofessor of Surgery in the Division of Vascular Surgery. Dr. Garcia-Toca ha
d previously served as an Assistant Professor of Surgery at Brown Universi
ty. Dr. Garcia Toca is a Staff Surgeon at Santa Clara Valley Medical Cent
er in San Jose.
\n
\nHis research interests include new thera
peutic strategies and outcomes for the management of vascular trauma\, cer
ebrovascular diseases\, dialysis access\, aortic dissection and aneurysms.
\n
\nABOUT OLIVER O. AALAMI
\nDr. Aala
mi is a Clinical Associate Professor of Vascular & Endovascular Surgery at
Stanford University and the Palo Alto VA and serves as the Lead Director
of Stanford’s Biodesign for Digital Health. He is the course director for
Biodesign for Digital Health\, Building for Digital Health and co-founder
of the open source project\, CardinalKit\, developed to support sensor-b
ased mobile research projects. His primary research focuses on clinically
validating the sensors in smartphones and smartwatches in patients with c
ardiovascular disease to further precision health implementation.
\n
\nHosted by: Garry Gold\, M.D.
\nSponsored by th
e PHIND Center and the Department of Radiology
\nTickets: https://stanford.zoom.us/we
binar/register/8616164417003/WN_5z--vTmvRu6l62kOUd9sZg.
X-TICKETS-URL:https://stanford.zoom.us/webinar/register/8616164417003/WN_5z
--vTmvRu6l62kOUd9sZg
END:VEVENT
BEGIN:VEVENT
UID:ai1ec-2033@web.stanford.edu/group/radweb/cgi-bin/radcalendar
DTSTAMP:20240410T061457Z
CATEGORIES;LANGUAGE=en-US:MIPS\,MIPS Seminar
CONTACT:Ashley Williams\; ashleylw@stanford.edu\; https://med.stanford.edu/
mips/events.html
DESCRIPTION:MIPS Seminar Series: Emerging nanophotonic platforms for infect
ious disease diagnostics: Re-imagining the conventional microbiology toolk
it\nJennifer Dionne\, PhD\nSenior Associate Vice Provost for Research Plat
forms/Shared Facilities\nAssociate Professor of Material Science and Engin
eering and\, by courtesy\, of Radiology (Molecular Imaging Program at Stan
ford)\nStanford University\n \nLocation: Zoom\nWebinar URL: https://stanfo
rd.zoom.us/j/95883654314\nDial: +1 650 724 9799 or +1 833 302 1536\nWebina
r ID: 958 8365 4314\nPasscode: 105586\n12:00pm – 12:45pm Seminar & Discuss
ion\nRSVP Here\n \nABSTRACT\nWe present our research controlling light at
the nanoscale for infectious disease diagnostics\, including detecting bac
teria at low concentration\, sensing COVID gene sequences\, and visualizin
g in-vivo inter-cellular forces. First\, we combine Raman spectroscopy and
deep learning to accurately classify bacteria by both species and antibio
tic resistance in a single step. We design a convolutional neural network
(CNN) for spectral data and train it to identify 30 of the most common bac
terial strains from single-cell Raman spectra\, achieving antibiotic treat
ment identification accuracies exceeding 99% and species identification ac
curacies similar to leading mass spectrometry identification techniques. O
ur combined Raman-CNN system represents a proof-of-concept for rapid\, cul
ture-free identification of bacterial isolates and antibiotic resistance.
Second\, we describe resonant nanophotonic surfaces\, known as “metasurfa
ces” that enable multiplexed detection of SARS-CoV-2 gene sequences. Our m
etasurfaces utilize guided mode resonances excited in high refractive inde
x nanostructures. The high quality factor modes produce a large amplificat
ion of the electromagnetic field near the nanostructures that increase the
response to targeted binding of nucleic acids\; simultaneously\, the opti
cal signal is beam-steered for multiplexed detection. We describe how this
platform can be manufactured at scale for portable\, low-cost assays. Fin
ally\, we introduce a new class of in vivo optical probes to monitor biolo
gical forces with high spatial resolution. Our design is based on upconver
ting nanoparticles that\, when excited in the near-infrared\, emit light o
f a different color and intensity in response to nano-to-microNewton force
s. The nanoparticles are sub-30nm in size\, do not bleach or photoblink\,
and can enable deep tissue imaging with minimal tissue autofluorescence. W
e present the design\, synthesis\, and characterization of these nanoparti
cles both in vitro and in vivo\, focusing on the forces generated by the r
oundworm C. elegans as it feeds and digests its bacterial food.\n \nABOUT
\nJennifer Dionne is the Senior Associate Vice Provost of Research Platfor
ms/Shared Facilities and an associate professor of Materials Science and E
ngineering and\, by courtesy\, of Radiology at Stanford. She is also an As
sociate Editor of Nano Letters\, director of the DOE-funded Photonics at T
hermodynamic Limits Energy Frontier Research Center\, and an affiliate fac
ulty of the Wu Tsai Neurosciences Institute\, the Institute for Immunity\,
Transplantation\, and Infection\, and Bio-X. Jen received her B.S. degree
s in Physics and Systems Science and Mathematics from Washington Universit
y in St. Louis\, her Ph. D. in Applied Physics at the California Institute
of Technology in 2009\, and her postdoctoral training in Chemistry at Ber
keley. Her research develops nanophotonic methods to observe and control
chemical and biological processes as they unfold with nanometer scale reso
lution\, emphasizing critical challenges in global health and sustainabili
ty. Her work has been recognized with the Alan T. Waterman Award\, a NIH D
irector’s New Innovator Award\, a Moore Inventor Fellowship\, the Material
s Research Society Young Investigator Award\, and the Presidential Early C
areer Award for Scientists and Engineers\, and was featured on Oprah’s lis
t of “50 Things that will make you say ‘Wow’!”. Beyond the lab\, Jen enjo
ys exploring the intersection of art and science\, long-distance cycling\,
and reliving her childhood with her two young sons.\n \nHosted by: Kather
ine Ferrara\, PhD\nSponsored by: Molecular Imaging Program at Stanford & t
he Department of Radiology\nTickets: https://stanford.zoom.us/webinar/regi
ster/7416069513520/WN_LIAnoCzYR8yLOnO-CDPgIQ.
DTSTART;TZID=America/Los_Angeles:20210422T120000
DTEND;TZID=America/Los_Angeles:20210422T124500
LOCATION:Zoom - See Description for Zoom Link
SEQUENCE:0
SUMMARY:MIPS Seminar – Jennifer Dionne\, PhD
URL:http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/event/mips-sem
inar-jennifer-dionne-phd/
X-COST-TYPE:external
X-WP-IMAGES-URL:thumbnail\;http://web.stanford.edu/group/radweb/cgi-bin/rad
calendar/wp-content/uploads/2019/10/jennifer-dionne_profilephoto-150x150.j
pg\;150\;150\;1\,medium\;http://web.stanford.edu/group/radweb/cgi-bin/radc
alendar/wp-content/uploads/2019/10/jennifer-dionne_profilephoto-300x300.jp
g\;300\;300\;1\,large\;http://web.stanford.edu/group/radweb/cgi-bin/radcal
endar/wp-content/uploads/2019/10/jennifer-dionne_profilephoto.jpg\;350\;35
0\;
X-ALT-DESC;FMTTYPE=text/html:\\n\\n\\n\\n\\nMIPS Semi
nar Series: Emerging nanophotonic platforms for infectious di
sease diagnostics: Re-imagining the conventional microbiology toolkit
\nJennifer
Dionne\, PhD
\nSenior Associate Vice
Provost for Research Platforms/Shared Facilities
\nAssociate Professor of Material Science and Engineering a
nd\, by courtesy\, of Radiology (Molecular Imaging Program at Stanford)
\nStanford University
\n
\nLocation: Zoom
\nWe
binar URL: https://stanford.zoom.us/j/95883654314
\nDial: +1
650 724 9799 or +1 833 302 1536
\nWebinar ID: 958 8365 4314
\nPa
sscode: 105586
\n12:00pm – 12:45pm Seminar & Discussion
\nRSVP Here
\n
\nABSTRACT
\nWe present our research controlling light at the nanoscale for infecti
ous disease diagnostics\, including detecting bacteria at low concentratio
n\, sensing COVID gene sequences\, and visualizing in-vivo inter-cellular
forces. First\, we combine Raman spectroscopy and deep learning to accurat
ely classify bacteria by both species and antibiotic resistance in a singl
e step. We design a convolutional neural network (CNN) for spectral data a
nd train it to identify 30 of the most common bacterial strains from singl
e-cell Raman spectra\, achieving antibiotic treatment identification accur
acies exceeding 99% and species identification accuracies similar to leadi
ng mass spectrometry identification techniques. Our combined Raman-CNN sys
tem represents a proof-of-concept for rapid\, culture-free identification
of bacterial isolates and antibiotic resistance. Second\, we describe res
onant nanophotonic surfaces\, known as “metasurfaces” that enable multiple
xed detection of SARS-CoV-2 gene sequences. Our metasurfaces utilize guide
d mode resonances excited in high refractive index nanostructures. The hig
h quality factor modes produce a large amplification of the electromagneti
c field near the nanostructures that increase the response to targeted bin
ding of nucleic acids\; simultaneously\, the optical signal is beam-steere
d for multiplexed detection. We describe how this platform can be manufact
ured at scale for portable\, low-cost assays. Finally\, we introduce a new
class of in vivo optical probes to monitor biological forces wit
h high spatial resolution. Our design is based on upconverting nanoparticl
es that\, when excited in the near-infrared\, emit light of a different co
lor and intensity in response to nano-to-microNewton forces. The nanoparti
cles are sub-30nm in size\, do not bleach or photoblink\, and can enable d
eep tissue imaging with minimal tissue autofluorescence. We present the de
sign\, synthesis\, and characterization of these nanoparticles both in vit
ro and in vivo\, focusing on the forces generated by the roundworm C.
elegans as it feeds and digests its bacterial food.
\n
\nABOUT
\nJennifer Dionne is the Senior Associate Vic
e Provost of Research Platforms/Shared Facilities and an associate profess
or of Materials Science and Engineering and\, by courtesy\, of Radiology a
t Stanford. She is also an Associate Editor of Nano Letters\, director of
the DOE-funded Photonics at Thermodynamic Limits Energy Frontier Research
Center\, and an affiliate faculty of the Wu Tsai Neurosciences Institute\,
the Institute for Immunity\, Transplantation\, and Infection\, and Bio-X.
Jen received her B.S. degrees in Physics and Systems Science and Mathemat
ics from Washington University in St. Louis\, her Ph. D. in Applied Physic
s at the California Institute of Technology in 2009\, and her postdoctoral
training in Chemistry at Berkeley. Her research develops nanophotonic me
thods to observe and control chemical and biological processes as they unf
old with nanometer scale resolution\, emphasizing critical challenges in g
lobal health and sustainability. Her work has been recognized with the Ala
n T. Waterman Award\, a NIH Director’s New Innovator Award\, a Moore Inven
tor Fellowship\, the Materials Research Society Young Investigator Award\,
and the Presidential Early Career Award for Scientists and Engineers\, an
d was featured on Oprah’s list of “50 Things that will make you say ‘Wow’!
”. Beyond the lab\, Jen enjoys exploring the intersection of art and scie
nce\, long-distance cycling\, and reliving her childhood with her two youn
g sons.
\n
\nHosted by: Katherine Ferrara\, PhD
\nSponsored by: Molecular Imaging Program at Stanford & the Departmen
t of Radiology
\nTickets: https://stanford.zoom.us/webinar/register/7416069513520/WN_
LIAnoCzYR8yLOnO-CDPgIQ.
X-TICKETS-URL:https://stanford.zoom.us/webinar/register/7416069513520/WN_LI
AnoCzYR8yLOnO-CDPgIQ
END:VEVENT
BEGIN:VEVENT
UID:ai1ec-2417@web.stanford.edu/group/radweb/cgi-bin/radcalendar
DTSTAMP:20240410T061457Z
CATEGORIES;LANGUAGE=en-US:Canary Center\,IBIIS\,MIPS\,PHIND\,Radiology\,RSL
CONTACT:Marta Flory\; flory@stanford.edu
DESCRIPTION:Targeted violence continues against Black Americans\, Asian Ame
ricans\, and all people of color. The department of radiology diversity co
mmittee is running a racial equity challenge to raise awareness of systemi
c racism\, implicit bias and related issues. Participants will be provided
a list of resources on these topics such as articles\, podcasts\, videos\
, etc.\, from which they can choose\, with the “challenge” of engaging wit
h one to three media sources prior to our session (some videos are as shor
t as a few minutes). Participants will meet in small-group breakout sessio
ns to discuss what they’ve learned and share ideas.\nPlease reach out to M
arta Flory\, flory@stanford.edu with questions. For details about the sess
ion\, including recommended resources and the Zoom link\, please reach out
to Meke Faaoso at mfaaoso@stanford.edu.\nTickets: https://docs.google.com
/spreadsheets/d/1ehKqHm32peHcm7NQJ427OaKIa9JpfHVunjBk66etZGc/edit?usp=shar
ing.
DTSTART;TZID=America/Los_Angeles:20210430T120000
DTEND;TZID=America/Los_Angeles:20210430T130000
LOCATION:Zoom
SEQUENCE:0
SUMMARY:Racial Equity Challenge: Race in society
URL:http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/event/racial-e
quity-challenge-race-in-society/
X-COST-TYPE:external
X-WP-IMAGES-URL:thumbnail\;http://web.stanford.edu/group/radweb/cgi-bin/rad
calendar/wp-content/uploads/2021/04/shield-150x150.png\;150\;150\;1\,mediu
m\;http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/wp-content/upl
oads/2021/04/shield.png\;225\;225\;
X-ALT-DESC;FMTTYPE=text/html:\\n\\n\\n\\n\\nTargeted violence continues against Black Ameri
cans\, Asian Americans\, and all people of color. The department of radiol
ogy diversity committee is running a racial equity challenge to raise awar
eness of systemic racism\, implicit bias and related issues. Participants
will be provided a list of resources on these topics such as articles\, po
dcasts\, videos\, etc.\, from which they can choose\, with the “challenge”
of engaging with one to three media sources prior to our session (some vi
deos are as short as a few minutes). Participants will meet in small-group
breakout sessions to discuss what they’ve learned and share ideas.
\n<
p>Please reach out to Marta Flory\, fl
ory@stanford.edu with questions. For details about the session\, inclu
ding recommended resources and the Zoom link\, please reach out to Meke Fa
aoso at mfaaoso@stanford.edu.\nTickets: https://docs.google.com/spreadsheets/d/1ehKqHm32peHcm7NQJ427Oa
KIa9JpfHVunjBk66etZGc/edit?usp=sharing.
X-TICKETS-URL:https://docs.google.com/spreadsheets/d/1ehKqHm32peHcm7NQJ427O
aKIa9JpfHVunjBk66etZGc/edit?usp=sharing
END:VEVENT
BEGIN:VEVENT
UID:ai1ec-1757@web.stanford.edu/group/radweb/cgi-bin/radcalendar
DTSTAMP:20240410T061457Z
CATEGORIES;LANGUAGE=en-US:Canary Center\,Early Cancer Detection Seminar Ser
ies
CONTACT:Ashley Williams\; ashleylw@stanford.edu\; https://canarycenter.stan
ford.edu/seminars.html
DESCRIPTION:CEDSS: “Building a Scalable Clinical Genomics Program: How tumo
r\, normal\, and plasma DNA sequencing are informing cancer care\, cancer
risk\, and cancer detection”\n \nMichael Berger\, Ph.D.\nElizabeth and Fel
ix Rohatyn Chair & Associate Director of the Marie-Josée and Henry R. Krav
is Center for Molecular Oncology\nMemorial Sloan Kettering Cancer Center\n
\nZoom Details\nMeeting URL: https://stanford.zoom.us/s/92559505314\nDial
: US: +1 650 724 9799 or +1 833 302 1536 (Toll Free)\nMeeting ID: 925 595
0 5314\nPasscode: 418727\n11:00am – 12:00pm Seminar & Discussion\nRSVP Her
e\n \nABSTRACT\nTumor molecular profiling is a fundamental component of pr
ecision oncology\, enabling the identification of oncogenomic mutations th
at can be targeted therapeutically. To accelerate enrollment to clinical t
rials of molecularly targeted agents and guide treatment selection\, we ha
ve established a center-wide\, prospective clinical sequencing program at
Memorial Sloan Kettering Cancer Center using a custom\, paired tumor-blood
normal sequencing assay (MSK-IMPACT)\, which we have used to profile more
than 50\,000 patients with solid tumors. Yet beyond just the characteriza
tion of tumor-specific alterations\, the inclusion of blood DNA has readil
y enabled the identification of germline risk alleles and somatic mutation
s associated with clonal hematopoiesis. To complement this approach\, we h
ave also implemented a ‘liquid biopsy’ cfDNA panel (MSK-ACCESS) for cancer
detection\, surveillance\, and treatment selection and monitoring. In my
talk\, I will describe the prevalence of somatic and germline genomic alte
rations in a real-world population\, the clinical benefits of cfDNA assess
ment\, and how clonal hematopoiesis can inform cancer risk and confound li
quid biopsy approaches to cancer detection.\n \nABOUT\nMichael Berger\, Ph
D\, holds the Elizabeth and Felix Rohatyn Chair and is Associate Director
of the Marie-Josée and Henry R. Kravis Center for Molecular Oncology at Me
morial Sloan Kettering Cancer Center\, a multidisciplinary initiative to p
romote precision oncology through genomic analysis to guide the diagnosis
and treatment of cancer patients. He is also an Associate Attending Geneti
cist in the Department of Pathology with expertise in cancer genomics\, co
mputational biology\, and high-throughput DNA sequencing technology. His l
aboratory is developing experimental and computational methods to characte
rize the genetic makeup of individual cancers and identify genomic biomark
ers of drug response and resistance. As Scientific Director of Clinical NG
S in the Molecular Diagnostics Service\, he oversees the development and b
ioinformatics associated with clinical sequencing assays\, and he helped l
ead the development and implementation of MSK-IMPACT\, a comprehensive FDA
-authorized tumor sequencing panel that been used to profile more than 60\
,000 tumors from advanced cancer patients at MSK. The resulting data have
enabled the characterization of somatic and germline biomarkers across man
y cancer types and the identification of mutations associated with clonal
hematopoiesis. Dr. Berger also led the development of a clinically validat
ed plasma cell-free DNA assay\, MSK-ACCESS\, which his laboratory is using
to explore tumor evolution\, acquired drug resistance\, and occult metast
atic disease. He received his Bachelor’s Degree in Physics from Princeton
University and his Ph.D. in Biophysics from Harvard University.\n \nHosted
by: Utkan Demirci\, Ph.D.\nSponsored by: The Canary Center & the Departme
nt of Radiology \nStanford University – School of Medicine\nTickets: https
://stanford.zoom.us/webinar/register/5516153318622/WN_MT7TTEciRoWmLVP9GlsJ
RA.
DTSTART;TZID=America/Los_Angeles:20210511T110000
DTEND;TZID=America/Los_Angeles:20210511T120000
LOCATION:Zoom - See Description for Zoom Link
SEQUENCE:0
SUMMARY:Cancer Early Detection Seminar Series – Michael Berger\, Ph.D.
URL:http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/event/cancer-e
arly-detection-seminar-series-michael-f-berger-ph-d/
X-COST-TYPE:external
X-WP-IMAGES-URL:thumbnail\;http://web.stanford.edu/group/radweb/cgi-bin/rad
calendar/wp-content/uploads/2019/10/berger_160204_07-2_3x2-150x150.jpg\;15
0\;150\;1\,medium\;http://web.stanford.edu/group/radweb/cgi-bin/radcalenda
r/wp-content/uploads/2019/10/berger_160204_07-2_3x2-300x200.jpg\;300\;200\
;1\,large\;http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/wp-con
tent/uploads/2019/10/berger_160204_07-2_3x2.jpg\;600\;400\;
X-ALT-DESC;FMTTYPE=text/html:\\n\\n\\n\\n\\nCEDSS: “Building a
Scalable Clinical Genomics Program: How tumor\, normal\, and plasma DNA se
quencing are informing cancer care\, cancer risk\, and cancer detection”
em>
\n
\nMichael Berger\, Ph.D.
\nElizabeth and Fel
ix Rohatyn Chair & Associate Director of the Marie-Josée and Henry R. Krav
is Center for Molecular Oncology
\nMemorial Sloan Kettering Cancer Ce
nter
\n
\nZoom Details
\nMeeti
ng URL: https://stanford.zoom.us/s/92559505314
\nDial: US: +1
650 724 9799 or +1 833 302 1536 (Toll Free)
\nMeeting ID: 925 5950
5314
\nPasscode: 418727
\n11:00am – 12:00pm Seminar & Discussio
n
\nRSVP Here
\n
\nABSTRAC
T
\nTumor molecular profiling is a fundamental component of
precision oncology\, enabling the identification of oncogenomic mutations
that can be targeted therapeutically. To accelerate enrollment to clinical
trials of molecularly targeted agents and guide treatment selection\, we
have established a center-wide\, prospective clinical sequencing program a
t Memorial Sloan Kettering Cancer Center using a custom\, paired tumor-blo
od normal sequencing assay (MSK-IMPACT)\, which we have used to profile mo
re than 50\,000 patients with solid tumors. Yet beyond just the characteri
zation of tumor-specific alterations\, the inclusion of blood DNA has read
ily enabled the identification of germline risk alleles and somatic mutati
ons associated with clonal hematopoiesis. To complement this approach\, we
have also implemented a ‘liquid biopsy’ cfDNA panel (MSK-ACCESS) for canc
er detection\, surveillance\, and treatment selection and monitoring. In m
y talk\, I will describe the prevalence of somatic and germline genomic al
terations in a real-world population\, the clinical benefits of cfDNA asse
ssment\, and how clonal hematopoiesis can inform cancer risk and confound
liquid biopsy approaches to cancer detection.
\n
\nAB
OUT
\nMichael Berger\, PhD\, holds the Elizabeth and Felix R
ohatyn Chair and is Associate Director of the Marie-Josée and Henry R. Kra
vis Center for Molecular Oncology at Memorial Sloan Kettering Cancer Cente
r\, a multidisciplinary initiative to promote precision oncology through g
enomic analysis to guide the diagnosis and treatment of cancer patients. H
e is also an Associate Attending Geneticist in the Department of Pathology
with expertise in cancer genomics\, computational biology\, and high-thro
ughput DNA sequencing technology. His laboratory is developing experimenta
l and computational methods to characterize the genetic makeup of individu
al cancers and identify genomic biomarkers of drug response and resistance
. As Scientific Director of Clinical NGS in the Molecular Diagnostics Serv
ice\, he oversees the development and bioinformatics associated with clini
cal sequencing assays\, and he helped lead the development and implementat
ion of MSK-IMPACT\, a comprehensive FDA-authorized tumor sequencing panel
that been used to profile more than 60\,000 tumors from advanced cancer pa
tients at MSK. The resulting data have enabled the characterization of som
atic and germline biomarkers across many cancer types and the identificati
on of mutations associated with clonal hematopoiesis. Dr. Berger also led
the development of a clinically validated plasma cell-free DNA assay\, MSK
-ACCESS\, which his laboratory is using to explore tumor evolution\, acqui
red drug resistance\, and occult metastatic disease. He received his Bache
lor’s Degree in Physics from Princeton University and his Ph.D. in Biophys
ics from Harvard University.
\n
\nHosted by: Utkan Demirc
i\, Ph.D.
\nSponsored by
: The Canary Center & the Department of Radiology
\nStanfor
d University – School of Medicine
\nTickets: https://stanford.zoom.us/webinar/registe
r/5516153318622/WN_MT7TTEciRoWmLVP9GlsJRA.
X-TICKETS-URL:https://stanford.zoom.us/webinar/register/5516153318622/WN_MT
7TTEciRoWmLVP9GlsJRA
END:VEVENT
BEGIN:VEVENT
UID:ai1ec-2385@web.stanford.edu/group/radweb/cgi-bin/radcalendar
DTSTAMP:20240410T061457Z
CATEGORIES;LANGUAGE=en-US:MIPS\,MIPS Seminar
CONTACT:Ashley Williams\; ashleylw@stanford.edu\; https://med.stanford.edu/
mips/events.html
DESCRIPTION:MIPS Special Seminar: Jubilant Biosys: Drug discovery and contr
act research services\, from target discovery to candidate selection\n \nT
homas Haywood\, PhD\nHead of International Radiochemistry Collaborations\n
Stanford University\n \nSaurabh Kapure\, MBA\nVice President\, Business De
velopment (USA & APAC)\nJubilant Biosys Limited\n \nJay Sheth\, MBA\nManag
er Business Development\, Drug Discovery Services\, and CDMO\nJubilant Bio
sys Limited\n \nLOCATION: Zoom\nMeeting URL: https://stanford.zoom.us/j/98
108346345\nDial: +1 650 724 9799 or +1 833 302 1536\nMeeting ID: 981 0834
6345\nPasscode: 397741\n\n\nSCHEDULE\n9:00-9:15 AM\, PT – Thomas Haywood
– Stanford Radiology projects\n9:15-9:30 AM\, PT – Saurabh Kapure – Introd
uction to Jubilant Biosys\, Scale-up and GMP manufacturing\n9:30-9:40 AM\,
PT – Jay Sheth – How Jubilant Biosys works with academic partners: exampl
es and case-studies\n9:40-10:00 AM\, PT – Moderated by Jason Thanh Lee –
Discussion\n \nABOUT\nJubilant Biosys\, an integrated contract research or
ganization in India with business offices in Asia and North America\, is a
leading collaborator for biotechnology and pharmaceutical companies\, wit
h in-depth expertise in discovery informatics\, medicinal chemistry\, stru
ctural biology\, and in vitro pharmacology services. Jubilant Biosys provi
des comprehensive drug discovery services and contract research services\,
from target discovery to candidate selection and with flexible business m
odels (FFS\, FTE and risk shared). This seminar will showcase case studies
from recent Stanford projects and a discussion of future opportunities.\n
\nSponsored by: Molecular Imaging Program at Stanford\, Department of Rad
iology
DTSTART;TZID=America/Los_Angeles:20210512T090000
DTEND;TZID=America/Los_Angeles:20210512T100000
LOCATION:Zoom - See Description for Zoom Link
SEQUENCE:0
SUMMARY:MIPS Special Seminar – Jubilant Biosys
URL:http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/event/mips-spe
cial-seminar-jubilant-biosys/
X-COST-TYPE:free
X-WP-IMAGES-URL:thumbnail\;http://web.stanford.edu/group/radweb/cgi-bin/rad
calendar/wp-content/uploads/2019/10/Headshots-for-Calendar-150x150.jpg\;15
0\;150\;1\,medium\;http://web.stanford.edu/group/radweb/cgi-bin/radcalenda
r/wp-content/uploads/2019/10/Headshots-for-Calendar.jpg\;210\;209\;
X-ALT-DESC;FMTTYPE=text/html:\\n\\n\\n\\n\\nMIPS Special Seminar: <
/strong>Jubilant Biosys: Drug discovery and contract research services
\, from target discovery to candidate selection
\n
\nThomas Haywood\, PhD
\nHead of International Radiochemi
stry Collaborations
\nStanford University
\n
\nS
aurabh Kapure\, MBA
\nVice President\, Business Development
(USA & APAC)
\nJubilant Biosys Limited
\n
\nJay
Sheth\, MBA
\nManager Business Development\, Drug Discovery
Services\, and CDMO
\nJubilant Biosys Limited
\n
\nLOCATION: Zoom
\nMeeting URL: https://stanford.zoom.us/j/9
8108346345
\nDial: +1 650 724 9799 or +1 833 302 1536
\nMeeting ID: 981 0834 6345
\nPasscode: 397741
p>\n\n\nSCHEDULE
\n9:
00-9:15 AM\, PT – Thomas Haywood – Stanford Radiolo
gy projects
\n9:15-9:30 AM\, PT – Saurabh Kapur
e – Introduction to Jubilant Biosys\, Scale-up and GMP manufactur
ing
\n9:30-9:40 AM\, PT – Jay Sheth –
How Jubilant Biosys works with academic partners: examples and case-studie
s
\n9:40-10:00 AM\, PT – Moderated by Jason Thanh Le
e – Discussion
\n
\nABOUT
\nJubilant Biosys\, an integrated contract research organization i
n India with business offices in Asia and North America\, is a leading col
laborator for biotechnology and pharmaceutical companies\, with in-depth e
xpertise in discovery informatics\, medicinal chemistry\, structural biolo
gy\, and in vitro pharmacology services. Jubilant Biosys provides
comprehensive drug discovery services and contract research services\, fr
om target discovery to candidate selection and with flexible business mode
ls (FFS\, FTE and risk shared). This seminar will showcase case studies fr
om recent Stanford projects and a discussion of future opportunities.
\n
\nSponsored by: Molecular Imaging Program at Stanford\, D
epartment of Radiology
\n
END:VEVENT
BEGIN:VEVENT
UID:ai1ec-2421@web.stanford.edu/group/radweb/cgi-bin/radcalendar
DTSTAMP:20240410T061457Z
CATEGORIES;LANGUAGE=en-US:PHIND\,PHIND Seminar Series
CONTACT:Ashley Williams\; ashleylw@stanford.edu
DESCRIPTION:PHIND Seminar Series: Multi-Cancer Early Detection Screening Te
sts – “Liquid Biopsy Tests” – Are Here – But Will Payers Provide Insurance
Coverage?\n \nPatricia A. Deverka\, MD\, MS\, MBE\nExecutive Director\nDe
verka Consulting\, LLC\n \nKathryn A. Phillips\, PhD\nProfessor of Health
Economics and Health Services Research\nFounding Director\, UCSF Center fo
r Translational and Policy Research on Personalized Medicine (TRANSPERS)\n
\nLocation: Zoom\nWebinar URL: https://stanford.zoom.us/s/99194110894\nDi
al: US: +1 650 724 9799 or +1 833 302 1536 (Toll Free)\nWebinar ID: 991 9
411 0894\nPasscode: 044958\n11:00am – 12:00pm Seminar & Discussion\nRSVP H
ere\n \nABSTRACT\nThe emergence of Multi-Cancer Early Detection Screening
Tests (MCED) – “liquid biopsy screening tests” – has generated enormous in
terest because they could fundamentally shift how cancer screening is done
. One company is already offering an MCED test for clinical use as a “lab
developed test” (LDT) – and thus addressing the question of “who will pay”
has become urgent. These tests offer potentially transformative screening
and clinical benefits\, but their characteristics present unique challeng
es to payer coverage decision-making and generate concerns about the poten
tially high cost of widespread adoption.\nWe will present our ongoing work
on examining the unique challenges that MCED present for payer coverage d
ecision-making\, drawing on our extensive experience with coverage and rei
mbursement for new technologies. We will focus on identifying the evidence
generation strategies that could be pursued now to inform payer decision-
making so that coverage policies can be developed that are appropriate and
equitable for this ground-breaking technology.\n \nABOUT PATRICIA A. DEVE
RKA\nDr. Deverka is the Executive Director at Deverka Consulting\, LLC whe
re she focuses on helping biotechnology companies and start-ups develop ev
idence to support payer coverage and clinical adoption of innovative techn
ologies. Her most recent projects have focused on breakthrough tests and
drugs focused on population genomic screening\, cancer\, and ultra-rare di
sorders. Prior to starting her consulting practice\, Dr. Deverka has work
ed in the fields of health economics and outcomes research in both non-pro
fit and for-profit settings as a researcher\, educator\, and department he
ad. She has extensive experience with patient-centered outcomes research\,
drug and diagnostic reimbursement planning\, cost- effectiveness analysis
\, and bioethical issues surrounding the use of new technologies. While wo
rking in academia and several non-profit firms\, she has participated in n
umerous NIH-funded studies to evaluate policy barriers to clinical integra
tion of new genomic technologies and has published extensively on strategi
es to promote evidence generation and data sharing. She is a member of the
National Human Genome Research Institute (NHGRI)’s Genomic Medicine Work
Group and serves as a member of NHGRI’s Advisory Council. Deverka has a me
dical degree from the University of Pittsburgh and is board certified in G
eneral Preventive Medicine and Public Health. She also has a master’s deg
ree in bioethics from the University of Pennsylvania and completed a polic
y fellowship at Duke University’s Institute for Genome Sciences and Policy
.\n \nABOUT KATHRYN A. PHILLIPS\nKathryn A. Phillips founded and leads the
UCSF Center for Translational and Policy Research on Personalized Medicin
e (TRANSPERS)\, which focuses on developing objective evidence on how to e
ffectively\, efficiently\, and equitably implement precision/personalized
medicine into health care. Kathryn has published over 150 peer-reviewed ar
ticles in major journals including JAMA\, New England Journal of Medicine\
, Science\, and Health Affairs. She has had continuous funding from NIH as
a PI for over 25 years and was recently awarded a 5-year NIH grant to exa
mine payer coverage and economic value for emerging genomic technologies (
cell-free DNA tests and tests based on polygenic risk scores). Kathryn ser
ves on the editorial boards for Health Affairs\, Value in Health\, JAMA In
ternal Medicine\, Genetics in Medicine\; is a member of the National Acade
my of Medicine Roundtable on Genomics and Precision Health\; and has serve
d on the governing Board of Directors for GenomeCanada and as an advisor t
o the FDA\, CDC\, and the President’s Council of Advisors on Science and T
echnology. She has also served as an advisor to many diagnostics\, sequenc
ing\, and pharmaceutical companies. Kathryn is Chair of the Global Economi
cs and Evaluation of Clinical Sequencing Working Group\, and a member of a
n evidence review committee for the Institute for Clinical and Economic Re
view (ICER). \n \n \nHosted by: Garry Gold\, M.D.\nSponsored by the PHIND
Center and the Department of Radiology\nTickets: https://stanford.zoom.us
/webinar/register/9516200549922/WN_q4_OV6KhRe6MKb_cPEC3GQ.
DTSTART;TZID=America/Los_Angeles:20210518T110000
DTEND;TZID=America/Los_Angeles:20210518T120000
LOCATION:Zoom - See Description for Zoom Link
SEQUENCE:0
SUMMARY:PHIND Seminar – Patricia A. Deverka\, MD\, MS\, MBE & Kathryn A. Ph
illips\, PhD
URL:http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/event/phind-se
minar-patricia-a-deverka-md-ms-mbe-kathryn-a-phillips-phd/
X-COST-TYPE:external
X-WP-IMAGES-URL:thumbnail\;http://web.stanford.edu/group/radweb/cgi-bin/rad
calendar/wp-content/uploads/2019/10/2020.5_SpeakerMashUp-150x126.jpg\;150\
;126\;1\,medium\;http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/
wp-content/uploads/2019/10/2020.5_SpeakerMashUp.jpg\;252\;126\;
X-ALT-DESC;FMTTYPE=text/html:\\n\\n\\n\\n\\nPHIND Seminar Series: Multi-C
ancer Early Detection Screening Tests – “Liquid Biopsy Tests” – Are Here –
But Will Payers Provide Insurance Coverage?
\n
\nPatricia A. Deverka\, MD\, MS\, MBE
\nExecutive Director\nDeverka Consulting\, LLC
\n
\nKathryn A. Philli
ps\, PhD
\nProfessor of Health Economics and Health Services
Research
\nFounding Director\, UCSF Center for Translational and
Policy Research on Personalized Medicine (TRANSPERS)
\n
\n
Location: Zoom
\nWebinar URL: https://stanford.zoom.us/s/99194
110894
\nDial: US: +1 650 724 9799 or +1 833 302 1536 (Toll Free
)
\nWebinar ID: 991 9411 0894
\nPasscode: 044958
\n11:00am
– 12:00pm Seminar & Discussion
\nRSVP Here
\n
\nABSTRACT
\nThe emergence of Multi-Can
cer Early Detection Screening Tests (MCED) – “liquid biopsy screening test
s” – has generated enormous interest because they could fundamentally shif
t how cancer screening is done. One company is already offering an MCED te
st for clinical use as a “lab developed test” (LDT) – and thus addressing
the question of “who will pay” has become urgent. These tests offer potent
ially transformative screening and clinical benefits\, but their character
istics present unique challenges to payer coverage decision-making and gen
erate concerns about the potentially high cost of widespread adoption.
\nWe will present our ongoing work on examining the unique challenges t
hat MCED present for payer coverage decision-making\, drawing on our exten
sive experience with coverage and reimbursement for new technologies. We w
ill focus on identifying the evidence generation strategies that could be
pursued now to inform payer decision-making so that coverage policies can
be developed that are appropriate and equitable for this ground-breaking t
echnology.
\n
\nABOUT PATRICIA A. DEVERKA
\nDr. Deverka is the Executive Director at Deverka Consulting\, LLC whe
re she focuses on helping biotechnology companies and start-ups develop ev
idence to support payer coverage and clinical adoption of innovative techn
ologies. Her most recent projects have focused on breakthrough tests and
drugs focused on population genomic screening\, cancer\, and ultra-rare di
sorders. Prior to starting her consulting practice\, Dr. Deverka has work
ed in the fields of health economics and outcomes research in both non-pro
fit and for-profit settings as a researcher\, educator\, and department he
ad. She has extensive experience with patient-centered outcomes research\,
drug and diagnostic reimbursement planning\, cost- effectiveness analysis
\, and bioethical issues surrounding the use of new technologies. While wo
rking in academia and several non-profit firms\, she has participated in n
umerous NIH-funded studies to evaluate policy barriers to clinical integra
tion of new genomic technologies and has published extensively on strategi
es to promote evidence generation and data sharing. She is a member of the
National Human Genome Research Institute (NHGRI)’s Genomic Medicine Work
Group and serves as a member of NHGRI’s Advisory Council. Deverka has a me
dical degree from the University of Pittsburgh and is board certified in G
eneral Preventive Medicine and Public Health. She also has a master’s deg
ree in bioethics from the University of Pennsylvania and completed a polic
y fellowship at Duke University’s Institute for Genome Sciences and Policy
.
\n
\nABOUT KATHRYN A. PHILLIPS
\nKath
ryn A. Phillips founded and leads the UCSF Center for Translational an
d Policy Research on Personalized Medicine (TRANSPERS)\, which focuse
s on developing objective evidence on how to effectively\, efficiently\, a
nd equitably implement precision/personalized medicine into health care. K
athryn has published over 150 peer-reviewed articles in major journals inc
luding JAMA\, New England Journal of Medicine\, Scie
nce\, and Health Affairs. She has had continuous funding fro
m NIH as a PI for over 25 years and was recently awarded a 5-year NIH gran
t to examine payer coverage and economic value for emerging genomic techno
logies (cell-free DNA tests and tests based on polygenic risk scores). Kat
hryn serves on the editorial boards for Health Affairs\, Valu
e in Health\, JAMA Internal Medicine\, Genetics in Medic
ine\; is a member of the National Academy of Medicine Roundtable on G
enomics and Precision Health\; and has served on the governing Board of Di
rectors for GenomeCanada and as an advisor to the FDA\, CDC\, and the Pres
ident’s Council of Advisors on Science and Technology. She has also served
as an advisor to many diagnostics\, sequencing\, and pharmaceutical compa
nies. Kathryn is Chair of the Global Economics and Evaluation of Clini
cal Sequencing Working Group\, and a member of an evidence review com
mittee for the Institute for Clinical and Economic Review (ICER).
\n
\n
\nHosted by: Garry Gold\
, M.D.
\nSponsored by the PHIND Center and the Department of
Radiology
\nTickets: https://stanford.zoom.us/webinar/register/9516200549922/WN_q4_O
V6KhRe6MKb_cPEC3GQ.
X-TICKETS-URL:https://stanford.zoom.us/webinar/register/9516200549922/WN_q4
_OV6KhRe6MKb_cPEC3GQ
END:VEVENT
BEGIN:VEVENT
UID:ai1ec-2453@web.stanford.edu/group/radweb/cgi-bin/radcalendar
DTSTAMP:20240410T061457Z
CATEGORIES;LANGUAGE=en-US:Radiology
CONTACT:
DESCRIPTION:Radiology Department-Wide Research Meeting\n• Research Announce
ments\n• Koen Nieman\, M.D.\, PhD – Coronary Artery Disease by Computed To
mography\n• Martin Willemink\, M.D.\, PhD – Translating Emerging Cardiovas
cular CT Techniques into the Clinical Setting\nLocation: Zoom – Details ca
n be found here: https://radresearch.stanford.edu\nMeetings will be the 3r
d Friday of each month.\n \nHosted by: Daniel Ennis\, PhD\nSponsored by: t
he the Department of Radiology
DTSTART;TZID=America/Los_Angeles:20210521T120000
DTEND;TZID=America/Los_Angeles:20210521T130000
SEQUENCE:0
SUMMARY:Radiology-Wide Research Meeting
URL:http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/event/radiolog
y-wide-research-meeting-5/
X-COST-TYPE:free
X-WP-IMAGES-URL:thumbnail\;http://web.stanford.edu/group/radweb/cgi-bin/rad
calendar/wp-content/uploads/2021/04/May-21-RWR-mtg-150x150.jpeg\;150\;150\
;1\,medium\;http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/wp-co
ntent/uploads/2021/04/May-21-RWR-mtg-300x200.jpeg\;300\;200\;1
X-ALT-DESC;FMTTYPE=text/html:\\n\\n\\n\\n\\nRadiology Department-W
ide Research Meeting
\n• Research Announcements
\n• Ko
en Nieman\, M.D.\, PhD – Coronary Artery Disease by Computed Tomography
\n• Martin Willemink\, M.D.\, PhD – Translating Emerging Cardiovascular
CT Techniques into the Clinical Setting
\nLocation: Zoom – Details can be found here: https://radresearch.stanfor
d.edu
\nMeetings will be the 3rd Friday of each month.
\n <
/p>\n
Hosted by: Daniel Ennis\, PhD
\nSponsored by: th
e the Department of Radiology
\n
END:VEVENT
BEGIN:VEVENT
UID:ai1ec-2161@web.stanford.edu/group/radweb/cgi-bin/radcalendar
DTSTAMP:20240410T061457Z
CATEGORIES;LANGUAGE=en-US:MIPS\,MIPS Seminar
CONTACT:Ashley Williams\; ashleylw@stanford.edu\; https://med.stanford.edu/
mips/events.html
DESCRIPTION:MIPS Seminar Series: Image-guided focal therapy for prostate ca
ncer\nGeoffrey Sonn\, MD\nAssistant Professor of Urology and\, by courtesy
\, of Radiology (Molecular Imaging Program at Stanford)\nStanford Universi
ty Medical Center\n \nLocation: Zoom\nWebinar URL: https://stanford.zoom.u
s/s/96126703618\nDial: +1 650 724 9799 or +1 833 302 1536\nWebinar ID: 961
2670 3618\nPasscode: 186059\n12:00pm – 12:45pm Seminar & Discussion\nRSVP
Here\n \nABSTRACT\nIn recent years\, prostate cancer treatment has increa
singly focused on selecting patients who are most likely to benefit and re
ducing harms from treatment. This has been seen both in adoption of active
surveillance for men with low-risk prostate cancer and emergence of image
-guided focal ablative therapy. While focal therapy causes fewer sexual an
d urinary side effects than conventional prostate cancer treatments\, many
questions remain about proper patient selection\, treatment planning\, an
d follow up care.\n \nImprovements in prostate MRI performance and interpr
etation have paved the way for adoption of focal therapy. However\, clinic
al challenges remain in prostate cancer imaging. This talk will describe p
rostate cancer focal therapy\, discuss patient selection\, and highlight t
he research efforts of my group to improve MRI interpretation to guide bio
psy and improve focal therapy performance.\n \nABOUT\nGeoffrey Sonn\, MD i
s a urologic oncologist who specializes in treating patients with prostate
and kidney cancer. He has a particular interest in cancer imaging\, MRI-U
ltrasound fusion targeted prostate biopsy\, prostate cancer focal therapy\
, and robotic surgery for prostate and kidney cancer. He is the principal
investigator of the first clinical trial in Northern California to use MRI
-guided focused ultrasound to treat prostate cancer. The goal of this tria
l is to treat prostate cancer with fewer side effects than surgery or radi
ation.\nDr. Sonn was born in Washington State and lived there until leavin
g for college at Georgetown. After graduating magna cum laude at Georgetow
n he returned to the West Coast for medical school at UCLA. Following medi
cal school\, Dr. Sonn completed a 6-year urology residency at Stanford whe
re he developed particular interests in the clinical care of patients with
urologic cancers and research in cancer imaging. Dr. Sonn completed a 2-y
ear urologic oncology fellowship at UCLA. Since completing his fellowship\
, Dr. Sonn has been at Stanford as an assistant professor in urology. Dr.
Sonn’s research is devoted to developing new cancer imaging techniques\, a
pplying artificial intelligence to find cancers on medical images\, and ap
plying new methods to treat prostate cancer with fewer side effects.\n \nH
osted by: Katherine Ferrara\, PhD\nSponsored by: Molecular Imaging Program
at Stanford & the Department of Radiology\nTickets: https://stanford.zoom
.us/webinar/register/8116097828282/WN_mfyC-_dUTwymWGqvmmF1zA.
DTSTART;TZID=America/Los_Angeles:20210527T120000
DTEND;TZID=America/Los_Angeles:20210527T124500
LOCATION:Zoom - See Description for Zoom Link
SEQUENCE:0
SUMMARY:MIPS Seminar – Geoffrey Sonn\, MD
URL:http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/event/mips-sem
inar-geoffrey-sonn-md/
X-COST-TYPE:external
X-WP-IMAGES-URL:thumbnail\;http://web.stanford.edu/group/radweb/cgi-bin/rad
calendar/wp-content/uploads/2019/10/geoffrey-sonn_profilephoto-150x150.jpg
\;150\;150\;1\,medium\;http://web.stanford.edu/group/radweb/cgi-bin/radcal
endar/wp-content/uploads/2019/10/geoffrey-sonn_profilephoto-300x300.jpg\;3
00\;300\;1\,large\;http://web.stanford.edu/group/radweb/cgi-bin/radcalenda
r/wp-content/uploads/2019/10/geoffrey-sonn_profilephoto.jpg\;350\;350\;
X-ALT-DESC;FMTTYPE=text/html:\\n\\n\\n\\n\\nMIPS Semina
r Series: Image-guided focal therapy for prostate cancer
\n
Geoffrey Sonn\, MD
a>
\nAssistant Professor of Urology and\, by courtesy\, of Radiology
(Molecular Imaging Program at Stanford)
\nStanford University Medical
Center
\n
\nLocation: Zoom
\nWebinar URL: https://stanford.zoom.u
s/s/96126703618
\nDial: +1 650 724 9799 or +1 833 302 1536
\nWebinar ID: 961 2670 3618
\nPasscode: 186059
\n12:00pm – 12:4
5pm Seminar & Discussion
\nRSVP Here
\n <
/p>\n
ABSTRACT
\nIn recent years\, prostate cance
r treatment has increasingly focused on selecting patients who are most li
kely to benefit and reducing harms from treatment. This has been seen both
in adoption of active surveillance for men with low-risk prostate cancer
and emergence of image-guided focal ablative therapy. While focal therapy
causes fewer sexual and urinary side effects than conventional prostate ca
ncer treatments\, many questions remain about proper patient selection\, t
reatment planning\, and follow up care.
\n
\nImprovements in prostate MRI performance and interpretation have paved th
e way for adoption of focal therapy. However\, clinical challenges remain
in prostate cancer imaging. This talk will describe prostate cancer focal
therapy\, discuss patient selection\, and highlight the research efforts o
f my group to improve MRI interpretation to guide biopsy and improve focal
therapy performance.
\n
\nABOUT
\nGeof
frey Sonn\, MD is a urologic oncologist who specializes in treating patien
ts with prostate and kidney cancer. He has a particular interest in cancer
imaging\, MRI-Ultrasound fusion targeted prostate biopsy\, prostate cance
r focal therapy\, and robotic surgery for prostate and kidney cancer. He i
s the principal investigator of the first clinical trial in Northern Calif
ornia to use MRI-guided focused ultrasound to treat prostate cancer. The g
oal of this trial is to treat prostate cancer with fewer side effects than
surgery or radiation.
\nDr. Sonn was born in Washington State and l
ived there until leaving for college at Georgetown. After graduating magna
cum laude at Georgetown he returned to the West Coast for medical school
at UCLA. Following medical school\, Dr. Sonn completed a 6-year urology re
sidency at Stanford where he developed particular interests in the clinica
l care of patients with urologic cancers and research in cancer imaging. D
r. Sonn completed a 2-year urologic oncology fellowship at UCLA. Since com
pleting his fellowship\, Dr. Sonn has been at Stanford as an assistant pro
fessor in urology. Dr. Sonn’s research is devoted to developing new cancer
imaging techniques\, applying artificial intelligence to find cancers on
medical images\, and applying new methods to treat prostate cancer with fe
wer side effects.
\n
\nHosted by: Katherine Ferrara\, PhD
\nSponsored by: Molecular Imaging Program at Stanford & the
Department of Radiology
\nTickets: https://stanford.zoom.us/webinar/register/8116097
828282/WN_mfyC-_dUTwymWGqvmmF1zA.
X-TICKETS-URL:https://stanford.zoom.us/webinar/register/8116097828282/WN_mf
yC-_dUTwymWGqvmmF1zA
END:VEVENT
BEGIN:VEVENT
UID:ai1ec-1573@web.stanford.edu/group/radweb/cgi-bin/radcalendar
DTSTAMP:20240410T061457Z
CATEGORIES;LANGUAGE=en-US:PHIND\,PHIND Seminar Series
CONTACT:Ashley Williams\; ashleylw@stanford.edu
DESCRIPTION:PHIND Seminar Series: Pervasive Computing With Everyday Devices
To Build & Sustain Resilience & Wellbeing\nPablo E. Paredes\, PhD\nClinic
al Assistant Professor\, Psychiatry and Behavioral Sciences and\, by court
esy\, Epidemiology and Population Health\nStanford University\n \nZoom Web
inar Details\nWebinar URL: https://stanford.zoom.us/s/99098874758\nDial: U
S: +1 650 724 9799 or +1 833 302 1536 (Toll Free)\nWebinar ID: 990 9887 4
758\nPasscode: 784858\n11:00am – 12:00pm Seminar & Discussion\n12:00pm – 1
2:15pm Reception\nRSVP Here\n \nABSTRACT\nAs society progresses towards in
creasing pervasive computing levels\, I design and build technology-enable
d solutions to repurpose everyday devices to help people build resilience
and grow wellbeing. I leverage biological and behavioral knowledge to desi
gn systems that balance user needs and health outcomes while mitigating su
rveillance and agency risks. In this talk\, I present my research on effic
acious and engaging sensors and interventions necessary in the population
and public health domains. I share a series of research projects exploring
and validating novel ideas on passive sensors – less dependent on subject
ive surveys or wearables – and subtle interventions that minimize workflo
w disruption. I show the promise of repurposing existing signals from comp
uting peripherals (i.e.\, mouse and trackpad) or cars (steering wheel) int
o “sensorless” sensors and repurposing existing media as just-in-time micr
o-interventions that can work across multiple scenarios and populations. I
discuss how these data could be used in collaboration with domain experts
to study topics as varied as the interaction between stress and productiv
ity in office workers\, burnout prevention among clinical practitioners\,
or the prevention of depression among rural health workers. Finally\, grou
nded in theories from neuroscience and behavioral economics\, I propose th
e evolution of everyday “mundane” devices\, such as chairs\, desks\, cars\
, or even urban lights\, into adaptive and autonomous wellbeing-optimizing
interventions. I close with a discussion of the research needed to system
atically study ethics in pervasive technology for resilience\, and wellbei
ng.\n \nABOUT\nPablo Paredes earned his Ph.D. in Computer Science from the
University of California\, Berkeley\, in 2015 with Prof. John Canny. He i
s currently a Clinical Assistant Professor in the Psychiatry and Behaviora
l Sciences Department and the Epidemiology and Population Health Departmen
t (by courtesy) at the Stanford University School of Medicine. He leads th
e Pervasive Wellbeing Technology Lab\, which houses a diverse group of stu
dents from multiple departments such as computer science\, electrical engi
neering\, mechanical engineering\, anthropology\, neuroscience\, and lingu
istics. Before joining the School of Medicine\, Dr. Paredes was a Postdoct
oral Researcher in the Computer Science Department at Stanford University
with Prof. James Landay. During his Ph.D. career\, he held internships on
behavior change and affective computing at Microsoft Research and Google.
He has been an active associate editor for the Interactive\, Mobile\, Wire
less\, and Ubiquitous Technology Journal (IMWUT) and a reviewer and editor
for multiple top CS and medical journals. Before 2010\, he was a senior s
trategic manager with Intel in Sao Paulo\, Brazil\, a lead product manager
with Telefonica in Quito\, Ecuador\, and an entrepreneur in his native Ec
uador and\, more recently\, in the US. In these roles\, he has had the opp
ortunity to hire and closely evaluate designers\, engineers\, business peo
ple\, and researchers in telecommunications and product development. Durin
g his academic career\, Dr. Paredes has advised close to 40 mentees\, incl
uding postdocs\, Ph.D.\, master’s\, and undergraduate students\, collabora
ted with colleagues from multiple departments across engineering\, medicin
e\, and the humanities\, and raised funding from NSF\, NIH\, and large mul
tidisciplinary intramural research projects.\n \nHosted by: Garry Gold\, M
.D.\nSponsored by the PHIND Center and the Department of Radiology\nTicket
s: https://stanford.zoom.us/webinar/register/8316220421859/WN_thRILWbcQK2h
9DllQXNjRQ.
DTSTART;TZID=America/Los_Angeles:20210615T110000
DTEND;TZID=America/Los_Angeles:20210615T120000
LOCATION:Zoom - See description for more information
SEQUENCE:0
SUMMARY:PHIND Seminar – Pablo E. Paredes\, Ph.D.
URL:http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/event/phind-se
minar-pablo-e-paredes-castro-ph-d/
X-COST-TYPE:external
X-WP-IMAGES-URL:thumbnail\;http://web.stanford.edu/group/radweb/cgi-bin/rad
calendar/wp-content/uploads/2019/10/self_picture_pablo_flowers-150x150.jpe
g\;150\;150\;1\,medium\;http://web.stanford.edu/group/radweb/cgi-bin/radca
lendar/wp-content/uploads/2019/10/self_picture_pablo_flowers-225x300.jpeg\
;225\;300\;1\,large\;http://web.stanford.edu/group/radweb/cgi-bin/radcalen
dar/wp-content/uploads/2019/10/self_picture_pablo_flowers-768x1024.jpeg\;6
40\;853\;1\,full\;http://web.stanford.edu/group/radweb/cgi-bin/radcalendar
/wp-content/uploads/2019/10/self_picture_pablo_flowers.jpeg\;2448\;3264\;
X-ALT-DESC;FMTTYPE=text/html:\\n\\n\\n\\n\\nPHIND Seminar Seri
es: Pervasive Computing With Everyday Devices To Build & Sustain Resil
ience & Wellbeing
\nPablo E. Paredes\, PhD
\nClini
cal Assistant Professor\, Psychiatry and Behavioral Sciences and\, by cour
tesy\, Epidemiology and Population Health
\nStanford University
\n
\nZoom Webinar Details
\nWebinar
URL: https://stanford.zoom.us/s/99098
874758
\nDial: US: +1 650 724 9799 or +1 833 302 1536 (Toll Free
)
\nWebinar ID: 990 9887 4758
\nPasscode: 784858
\n11:00am
– 12:00pm Seminar & Discussion
\n12:00pm – 12:15pm Reception
\n
RSVP Here
\n
\nABSTRACT
\nAs society progresses towards increasing pervasive computing leve
ls\, I design and build technology-enabled solutions to repurpose everyday
devices to help people build resilience and grow wellbeing. I leverage bi
ological and behavioral knowledge to design systems that balance user need
s and health outcomes while mitigating surveillance and agency risks. In t
his talk\, I present my research on efficacious and engaging sensors and i
nterventions necessary in the population and public health domains. I shar
e a series of research projects exploring and validating novel ideas on pa
ssive sensors – less dependent on subjective surveys or wearables – and s
ubtle interventions that minimize workflow disruption. I show the promise
of repurposing existing signals from computing peripherals (i.e.\, mouse a
nd trackpad) or cars (steering wheel) into “sensorless” sensors and repurp
osing existing media as just-in-time micro-interventions that can work acr
oss multiple scenarios and populations. I discuss how these data could be
used in collaboration with domain experts to study topics as varied as the
interaction between stress and productivity in office workers\, burnout p
revention among clinical practitioners\, or the prevention of depression a
mong rural health workers. Finally\, grounded in theories from neuroscienc
e and behavioral economics\, I propose the evolution of everyday “mundane”
devices\, such as chairs\, desks\, cars\, or even urban lights\, into ada
ptive and autonomous wellbeing-optimizing interventions. I close with a di
scussion of the research needed to systematically study ethics in pervasiv
e technology for resilience\, and wellbeing.
\n
\nABO
UT
\nPablo Paredes earned his Ph.D. in Computer Science from
the University of California\, Berkeley\, in 2015 with Prof. John Canny.
He is currently a Clinical Assistant Professor in the Psychiatry and Behav
ioral Sciences Department and the Epidemiology and Population Health Depar
tment (by courtesy) at the Stanford University School of Medicine. He lead
s the Pervasive Wellbeing Technology Lab\, which houses a diverse group of
students from multiple departments such as computer science\, electrical
engineering\, mechanical engineering\, anthropology\, neuroscience\, and l
inguistics. Before joining the School of Medicine\, Dr. Paredes was a Post
doctoral Researcher in the Computer Science Department at Stanford Univers
ity with Prof. James Landay. During his Ph.D. career\, he held internships
on behavior change and affective computing at Microsoft Research and Goog
le. He has been an active associate editor for the Interactive\, Mobile\,
Wireless\, and Ubiquitous Technology Journal (IMWUT) and a reviewer and ed
itor for multiple top CS and medical journals. Before 2010\, he was a seni
or strategic manager with Intel in Sao Paulo\, Brazil\, a lead product man
ager with Telefonica in Quito\, Ecuador\, and an entrepreneur in his nativ
e Ecuador and\, more recently\, in the US. In these roles\, he has had the
opportunity to hire and closely evaluate designers\, engineers\, business
people\, and researchers in telecommunications and product development. D
uring his academic career\, Dr. Paredes has advised close to 40 mentees\,
including postdocs\, Ph.D.\, master’s\, and undergraduate students\, colla
borated with colleagues from multiple departments across engineering\, med
icine\, and the humanities\, and raised funding from NSF\, NIH\, and large
multidisciplinary intramural research projects.
\n
\nHos
ted by: Garry Gold\, M.D.
\nSponsored by the PHIND Center an
d the Department of Radiology
\nTickets: https://stanford.zoom.us/webinar/register/83
16220421859/WN_thRILWbcQK2h9DllQXNjRQ.
X-TICKETS-URL:https://stanford.zoom.us/webinar/register/8316220421859/WN_th
RILWbcQK2h9DllQXNjRQ
END:VEVENT
BEGIN:VEVENT
UID:ai1ec-2725@web.stanford.edu/group/radweb/cgi-bin/radcalendar
DTSTAMP:20240410T061457Z
CATEGORIES;LANGUAGE=en-US:PHIND\,PHIND Seminar Series
CONTACT:Ashley Williams\; ashleylw@stanford.edu
DESCRIPTION:PHIND & CDH Seminar: “The Invisible Future of Health Monitoring
”\nJoin Stanford CDH and PHIND on Wednesday\, June 23rd at 3:15 PM PDT to
hear some of the industry’s leading experts talk about embedded sensors\,
longitudinal data collection\, the future of remote monitoring\, and real-
world applications of precision health technologies. The panel will featur
e: Nicolas Genain\, MS\, Withings\; John O Moore MD\, PhD\, Fitbit Health
Solutions at Google\; Pablo Paredes\, PhD\, MBA\, MS\, Stanford University
\; and Michael Synder\, PhD\, Stanford University. The discussion will be
moderated by Jun (Alex) Gao\, MS\, Samsung America.\n \nZoom Webinar Detai
ls\nWebinar URL: https://stanford.zoom.us/s/96984014176\nDial: US: +1 650
724 9799 or +1 833 302 1536 (Toll Free)\nWebinar ID: 969 8401 4176\nPassc
ode: 375941\n3:15pm – 4:15pm: Panel Discussion\nRSVP Here\n \n \nSponsored
by the PHIND Center and Center for Digital Health\nTickets: https://stanf
ord.zoom.us/webinar/register/7016228432975/WN_7RpA06gIQICRCH6bzQjt3w.
DTSTART;TZID=America/Los_Angeles:20210623T151500
DTEND;TZID=America/Los_Angeles:20210623T161500
LOCATION:Zoom - See Description for Zoom Link
SEQUENCE:0
SUMMARY:“The Invisible Future of Health Monitoring” – PHIND & CDH Seminar
URL:http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/event/the-invi
sible-future-of-health-monitoring-phind-cdh-seminar/
X-COST-TYPE:external
X-WP-IMAGES-URL:thumbnail\;http://web.stanford.edu/group/radweb/cgi-bin/rad
calendar/wp-content/uploads/2019/10/June-23rd-webinar-external-calendar-ti
le-01-150x150.png\;150\;150\;1\,medium\;http://web.stanford.edu/group/radw
eb/cgi-bin/radcalendar/wp-content/uploads/2019/10/June-23rd-webinar-extern
al-calendar-tile-01-300x205.png\;300\;205\;1\,large\;http://web.stanford.e
du/group/radweb/cgi-bin/radcalendar/wp-content/uploads/2019/10/June-23rd-w
ebinar-external-calendar-tile-01-1024x700.png\;640\;438\;1\,full\;http://w
eb.stanford.edu/group/radweb/cgi-bin/radcalendar/wp-content/uploads/2019/1
0/June-23rd-webinar-external-calendar-tile-01.png\;1251\;855\;
X-ALT-DESC;FMTTYPE=text/html:\\n\\n\\n\\n\\nPH
IND & CDH Seminar: “The Invisible Future of Health Monitoring”
\nJoin Stanford
CDH and PHIN
D on Wednesday\, June 23rd at 3:15 PM PDT to hear some of the industry
’s leading experts talk about embedded sensors\, longitudinal data collect
ion\, the future of remote monitoring\, and real-world applications of pre
cision health technologies. The panel will feature: Nicolas G
enain\, MS\, Withings\; John O Moore MD\, PhD\, Fitbit Health Solutions at Google
a>\; Pablo Paredes\, PhD\, MBA\, MS\, Stanford University\; and Michael Synder\
, PhD\, Stanford University. The discussion will be moderated by Jun (Alex) Gao\, M
S\, Samsung America.
\n
\nZoom Webinar Detail
s
\nWebinar URL: https://stanford.zoom
.us/s/96984014176
\nDial: US: +1 650 724 9799 or +1 833 302 1536
(Toll Free)
\nWebinar ID: 969 8401 4176
\nPasscode: 375941
\n3:15pm – 4:15pm: Panel Discussion
\nRSVP Here<
/a>
\n
\n
\nSponsored by the PHIND Center and Cent
er for Digital Health
\nTickets: https://stanford.zoom.us/webinar/register/7016228432
975/WN_7RpA06gIQICRCH6bzQjt3w.
X-TICKETS-URL:https://stanford.zoom.us/webinar/register/7016228432975/WN_7R
pA06gIQICRCH6bzQjt3w
END:VEVENT
BEGIN:VEVENT
UID:ai1ec-2627@web.stanford.edu/group/radweb/cgi-bin/radcalendar
DTSTAMP:20240410T061457Z
CATEGORIES;LANGUAGE=en-US:MIPS
CONTACT:Ashley Williams\; ashleylw@stanford.edu
DESCRIPTION:Molecular Imaging in Neuroscience – MIPS Mini-Retreat\nHosted b
y: Dr. Michelle L. James\, PhD\n\nSponsored by: Department of Radiology\,
Molecular Imaging Program at Stanford\n \n\n\n\n\n\n\n\n\nThe MIPS Mini-re
treat series brings together members of the MIPS and greater School of Med
icine community to discuss current opportunities for research and collabor
ations. During each mini-retreat we will discuss a different topic and we
invite all those interested to attend. The mini-retreats are roughly two h
ours in length with ample time for discussion throughout. We hope you can
join us and spark new collaborations!\n\n\n\n\n \nZoom Webinar Information
\nWebinar URL: https://stanford.zoom.us/j/92903233643\nDial: US: +1 650 72
4 9799 or +1 833 302 1536 (Toll Free)\nWebinar ID: 929 0323 3643\nPasscod
e: 146018\n \nTentative Agenda (all times are in PST)\n8:00-8:05 AM – Open
ing Remarks – Michelle James\, PhD\n8:05-8:55 AM – Overview and Imaging-ba
sed Collaboration: Department of Neurology\, Neurosurgery\, Pathology\, Ps
ychiatry\, and Nuclear Medicine (Frank M. Longo\, MD\, PhD\, Michael Lim\,
MD\, Thomas Montine\, MD\, PhD\, Victor G. Carrión\, MD\, and Guido David
zon\, MD)\n8:55-9:20 AM – Faculty Introductions: All interested MIPS facul
ty on the call give a 2-minute introduction including their interest in co
llaborating with Neurology\, Pathology\, Neurosurgery\, and/or Psychiatry
and Behavioral Sciences departments.\n9:20-9:40 AM – Recent center proposa
ls and possible mechanisms: UDALL Collaboration – Michelle James\, PhD and
Kathleen Poston\, MD\, MS\n9:40-10:00 AM – Discussion – Moderated by: Mic
helle James\, PhD and Katherine Ferrara\, PhD
DTSTART;TZID=America/Los_Angeles:20210630T080000
DTEND;TZID=America/Los_Angeles:20210630T100000
LOCATION:Virtual Event
SEQUENCE:0
SUMMARY:Molecular Imaging in Neuroscience – MIPS Mini-Retreat
URL:http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/event/molecula
r-imaging-in-neuroscience-mips-mini-retreat/
X-COST-TYPE:free
X-WP-IMAGES-URL:thumbnail\;http://web.stanford.edu/group/radweb/cgi-bin/rad
calendar/wp-content/uploads/2019/10/Mini-Retreat-Tile_6.30.2021-6-150x150.
jpg\;150\;150\;1\,medium\;http://web.stanford.edu/group/radweb/cgi-bin/rad
calendar/wp-content/uploads/2019/10/Mini-Retreat-Tile_6.30.2021-6-300x205.
jpg\;300\;205\;1
X-ALT-DESC;FMTTYPE=text/html:\\n\\n\\n\\n\\n\n
\n
\n
Molecular I
maging in Neuroscience – MIPS Mini-Retreat
\n
Hosted by: Dr. Michelle L. James\, PhD
\n
\n
Sponsored by: Departme
nt of Radiology\, Molecular Imaging Program at Stanford
\n
\n
\n
\n
\n
\n\n
\n
\n
\n
The M
IPS Mini-retreat series brings together members of the MIPS and greater Sc
hool of Medicine community to discuss current opportunities for research a
nd collaborations. During each mini-retreat we will discuss a different to
pic and we invite all those interested to attend. The mini-retreats are ro
ughly two hours in length with ample time for discussion throughout. We ho
pe you can join us and spark new collaborations!
\n
\n
\n\n
\n
\n
Zoom Webinar Information
\nWebinar URL: htt
ps://stanford.zoom.us/j/92903233643
\nDial: US: +1 650 724 9799
or +1 833 302 1536 (Toll Free)
\nWebinar ID: 929 0323 3643
\nPas
scode: 146018
\n
\n
Tentative Agenda (all times ar
e in PST)
\n8:00-8:05 AM – Opening Rem
arks – Michelle Jam
es\, PhD
\n8:05-8:55 AM – Overview and Imaging-b
ased Collaboration: Department of Neurology\, Neurosurgery\, Pathology\, P
sychiatry\, and Nuclear Medicine (Frank M. Longo\, MD\, PhD\, Michael Lim\, MD\, Thomas Montine\, MD\, PhD\, Victor G. Carrión\, MD\, and Guido Davidzon\, MD)\n8:55-9:20 AM – Faculty Introductions: All inter
ested MIPS faculty on the call give a 2-minute introduction including thei
r interest in collaborating with Neurology\, Pathology\, Neurosurgery\, an
d/or Psychiatry and Behavioral Sciences departments.
\n9
:20-9:40 AM – Recent center proposals and possible mechanisms: UD
ALL Collaboration – Michelle James\, PhD and Kathleen Poston\, MD\, MS
\n9:40-10:00
AM – Discussion – Moderated by: Michelle James\, PhD and Katherine Ferrara\, PhD
\n
END:VEVENT
BEGIN:VEVENT
UID:ai1ec-2803@web.stanford.edu/group/radweb/cgi-bin/radcalendar
DTSTAMP:20240410T061457Z
CATEGORIES;LANGUAGE=en-US:AIMI\,IBIIS\,Radiology\,RSL
CONTACT:
DESCRIPTION:Radiology Department-Wide Research Meeting\n• Research Announce
ments\n• Mirabela Rusu\, PhD – Learning MRI Signatures of Aggressive Prost
ate Cancer: Bridging the Gap between Digital Pathologists and Digital Radi
ologists\n• Akshay Chaudhari\, PhD – Data-Efficient Machine Learning for M
edical Imaging\nLocation: Zoom – Details can be found here: https://radres
earch.stanford.edu\nMeetings will be the 3rd Friday of each month.\n \nHos
ted by: Kawin Setsompop\, PhD\nSponsored by: the the Department of Radiolo
gy
DTSTART;TZID=America/Los_Angeles:20210716T120000
DTEND;TZID=America/Los_Angeles:20210716T130000
LOCATION:Zoom – Details can be found here: https://radresearch.stanford.edu
SEQUENCE:0
SUMMARY:Radiology-Wide Research Conference
URL:http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/event/radiolog
y-wide-research-conference/
X-COST-TYPE:free
X-WP-IMAGES-URL:thumbnail\;http://web.stanford.edu/group/radweb/cgi-bin/rad
calendar/wp-content/uploads/2021/07/RWRC-July-150x150.jpeg\;150\;150\;1\,m
edium\;http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/wp-content
/uploads/2021/07/RWRC-July-300x195.jpeg\;300\;195\;1\,large\;http://web.st
anford.edu/group/radweb/cgi-bin/radcalendar/wp-content/uploads/2021/07/RWR
C-July.jpeg\;443\;288\;
X-ALT-DESC;FMTTYPE=text/html:\\n\\n\\n
\\n\\n
\n
Radiology Department-Wide Research Meeting
\n
•
Research Announcements
\n• Mirabela Rusu\, PhD – Learning MRI Signat
ures of Aggressive Prostate Cancer: Bridging the Gap between Digital Patho
logists and Digital Radiologists
\n• Akshay Chaudhari\, PhD – Data-Ef
ficient Machine Learning for Medical Imaging
\n
Location: Zoom – Details can be found here: https://radresearch.st
anford.edu
\nMeetings will be the 3rd Friday of each month.
\n
\n
Hosted by: Kawin Setsompop\, PhD
\nSponsore
d by: the the Department of Radiology
\n
\n\n
END:VEVENT
BEGIN:VEVENT
UID:ai1ec-2763@web.stanford.edu/group/radweb/cgi-bin/radcalendar
DTSTAMP:20240410T061457Z
CATEGORIES;LANGUAGE=en-US:Radiology
CONTACT:Ashley Williams\; ashleylw@stanford.edu\; http://radweb.su.domains/
gambhirsymposium/
DESCRIPTION:Dr. Sanjiv Sam Gambhir was a visionary who had a profound impac
t on the world of science and humanity. As a leader and pioneer in the fie
lds of molecular imaging\, early detection of cancer\, and precision healt
h\, his enduring legacy can be seen in the research and innovations contin
uing in these fields today.\nThe Gambhir Symposium aims to celebrate Dr. G
ambhir’s illustrious career and continue down the paths he forged by highl
ighting the work still ongoing in the fields he helped to cultivate. Join
us to hear researchers and collaborators share current thoughts and future
outlooks on topics developed with Sam.\nWe hope you can join us for the 2
021 Virtual Gambhir Symposium.\nThe event is fully virtual and the livestr
eam link will be posted on the website closer to the event.\n \nSponsored
by: Department of Radiology at Stanford \nTickets: https://www.onlineregis
trationcenter.com/Gambhir2021.
DTSTART;TZID=America/Los_Angeles:20210719T083000
DTEND;TZID=America/Los_Angeles:20210719T160000
LOCATION:Virtual Event
SEQUENCE:0
SUMMARY:Gambhir Symposium
URL:http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/event/gambhir-
symposium/
X-COST-TYPE:external
X-WP-IMAGES-URL:thumbnail\;http://web.stanford.edu/group/radweb/cgi-bin/rad
calendar/wp-content/uploads/2019/10/calendar-square-150x150.png\;150\;150\
;1\,medium\;http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/wp-co
ntent/uploads/2019/10/calendar-square-300x205.png\;300\;205\;1
X-ALT-DESC;FMTTYPE=text/html:\\n\\n\\n
\\n\\n
Dr. Sanjiv Sam Gambhir was a v
isionary who had a profound impact on the world of science and humanity. A
s a leader and pioneer in the fields of molecular imaging\, early detectio
n of cancer\, and precision health\, his enduring legacy can be seen in th
e research and innovations continuing in these fields today.
\n
The G
ambhir Symposium aims to celebrate Dr. Gambhir’s illustrious career and co
ntinue down the paths he forged by highlighting the work still ongoing in
the fields he helped to cultivate. Join us to hear researchers and collabo
rators share current thoughts and future outlooks on topics developed with
Sam.
\n
We hope you can join us for the 2021 Virtual Gambhir Symposi
um.
\n
The event is fully virtual and the livestream link wil
l be posted on the website closer to the event.
\n
\n
Sponsored by: Department of Radio
logy at Stanford
\n
Tickets: https://www
.onlineregistrationcenter.com/Gambhir2021.
X-TICKETS-URL:https://www.onlineregistrationcenter.com/Gambhir2021
END:VEVENT
BEGIN:VEVENT
UID:ai1ec-1595@web.stanford.edu/group/radweb/cgi-bin/radcalendar
DTSTAMP:20240410T061457Z
CATEGORIES;LANGUAGE=en-US:PHIND\,PHIND Seminar Series
CONTACT:Ashley Williams\; ashleylw@stanford.edu\; https://med.stanford.edu/
phind/events/2021.html
DESCRIPTION:PHIND Seminar Series: Plastic-based sensors for wearable techno
logies: fundamentals and applications\n \nAlberto Salleo\, Ph.D.\nProfesso
r of Material Sciences and Engineering\nStanford University\n \nZoom Webin
ar Details\nWebinar URL: https://stanford.zoom.us/s/92646686705\nDial: US:
+1 650 724 9799 or +1 833 302 1536 (Toll Free)\nWebinar ID: 926 4668 670
5\nPasscode: 270341\n11:00am – 12:00pm Seminar & Discussion\nRSVP Here\n
\nABSTRACT\nThe continuous monitoring of human health can greatly benefit
from devices that can be worn comfortably or seamlessly integrated in hous
ehold objects\, constituting “health-centered” domotics. One of the key as
pects for these devices to be successful is to be invisibly integrated and
disappear in the background of our lives. Our group works on thin film de
vices made with plastic materials that can be used for electrochemically s
ensing of common analytes from easily accessible bodily fluids (e.g. sweat
\, saliva\, urine) and can be easily multiplexed. I will describe electroc
hemical transistors that detect ionic species either directly present in b
ody fluids or resulting from a selective enzymatic reaction (e.g. ammonia
from creatinine) at physiological levels. I will also show that non-charge
d molecules can be detected by making use of custom-processed polymer memb
ranes that act as “synthetic enzymes”. Using these membranes in conjunctio
n with electrochemical transistors we demonstrate that we are able to meas
ure physiological levels of cortisol in real human sweat. Importantly\, tr
ansistors can amplify signals and I will show what architectures must be u
sed to observe 1000x amplification of sensing currents.\nFinally we have d
eveloped a process that allows us to fabricate sensor arrays on flexible s
ubstrates thereby opening the door towards ultra-thin\, flexible sensor ar
rays for wearable technologies.\n \nABOUT\nAlberto Salleo is currently Ful
l Professor of Materials Science and Department Chair at Stanford Universi
ty. Alberto Salleo holds a Laurea degree in Chemistry from La Sapienza and
graduated as a Fulbright Fellow with a PhD in Materials Science from UC B
erkeley in 2001. From 2001 to 2005 Salleo was first post-doctoral research
fellow and successively member of research staff at Xerox Palo Alto Resea
rch Center. In 2005 Salleo joined the Materials Science and Engineering De
partment at Stanford as an Assistant Professor in 2006. Salleo is a Princi
pal Editor of MRS Communications since 2011.While at Stanford\, Salleo won
the NSF Career Award\, the 3M Untenured Faculty Award\, the SPIE Early Ca
reer Award\, the Tau Beta Pi Excellence in Undergraduate Teaching Award\,
and the Gores Award for Excellence in Teaching\, Stanford’s highest teachi
ng award. He has been a Thomson Reuters Highly Cited Researcher since 2015
\, recognizing that he ranks in the top 1% cited researchers in his field.
\n \nHosted by: Garry Gold\, M.D.\nSponsored by the PHIND Center and the D
epartment of Radiology\nTickets: https://stanford.zoom.us/webinar/register
/2816249009305/WN_lUezgp98RMKzD7rC6oeRFg.
DTSTART;TZID=America/Los_Angeles:20210720T110000
DTEND;TZID=America/Los_Angeles:20210720T120000
LOCATION:Zoom - See Description for Zoom Link
SEQUENCE:0
SUMMARY:PHIND Seminar – Alberto Salleo\, Ph.D.
URL:http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/event/phind-se
minar-alberto-salleo-ph-d/
X-COST-TYPE:external
X-WP-IMAGES-URL:thumbnail\;http://web.stanford.edu/group/radweb/cgi-bin/rad
calendar/wp-content/uploads/2019/10/alberto-salleo_profilephoto-150x150.jp
g\;150\;150\;1\,medium\;http://web.stanford.edu/group/radweb/cgi-bin/radca
lendar/wp-content/uploads/2019/10/alberto-salleo_profilephoto-300x300.jpg\
;300\;300\;1\,large\;http://web.stanford.edu/group/radweb/cgi-bin/radcalen
dar/wp-content/uploads/2019/10/alberto-salleo_profilephoto.jpg\;350\;350\;
X-ALT-DESC;FMTTYPE=text/html:\\n\\n\\n
\\n\\n
PHIND Seminar Seri
es: Plastic-based sensors for wearable technologies: fundamentals and
applications
\n
\n
Alberto Salleo\, Ph.D.
\nProfes
sor of Material Sciences and Engineering
\nStanford University
\n<
p> \n
Zoom Webinar Details
\nWebinar
URL: https://stanford.zoom.us/s/92646686705
\nDial: US: +1 65
0 724 9799 or +1 833 302 1536 (Toll Free)
\nWebinar ID: 926 4668 670
5
\nPasscode: 270341
\n
11:00am – 12:00pm Seminar & Discussion\nRSVP Here
\n
\n
ABSTRACT
strong>
\nThe continuous monitoring of human health can greatly benef
it from devices that can be worn comfortably or seamlessly integrated in h
ousehold objects\, constituting “health-centered” domotics. One of the key
aspects for these devices to be successful is to be invisibly integrated
and disappear in the background of our lives. Our group works on thin film
devices made with plastic materials that can be used for electrochemicall
y sensing of common analytes from easily accessible bodily fluids (e.g. sw
eat\, saliva\, urine) and can be easily multiplexed. I will describe elect
rochemical transistors that detect ionic species either directly present i
n body fluids or resulting from a selective enzymatic reaction (e.g. ammon
ia from creatinine) at physiological levels. I will also show that non-cha
rged molecules can be detected by making use of custom-processed polymer m
embranes that act as “synthetic enzymes”. Using these membranes in conjunc
tion with electrochemical transistors we demonstrate that we are able to m
easure physiological levels of cortisol in real human sweat. Importantly\,
transistors can amplify signals and I will show what architectures must b
e used to observe 1000x amplification of sensing currents.
\n
Finally
we have developed a process that allows us to fabricate sensor arrays on
flexible substrates thereby opening the door towards ultra-thin\, flexible
sensor arrays for wearable technologies.
\n
\n
ABOUT<
/strong>
\nAlberto Salleo is currently Full Professor of Materials Sc
ience and Department Chair at Stanford University. Alberto Salleo holds a
Laurea degree in Chemistry from La Sapienza and graduate
d as a Fulbright Fellow with a PhD in Materials Science from UC Berkeley i
n 2001. From 2001 to 2005 Salleo was first post-doctoral research fellow a
nd successively member of research staff at Xerox Palo Alto Research Cente
r. In 2005 Salleo joined the Materials Science and Engineering Department
at Stanford as an Assistant Professor in 2006. Salleo is a Principal Edito
r of MRS Communications since 2011.While at Stanford\, Salleo won the NSF
Career Award\, the 3M Untenured Faculty Award\, the SPIE Early Career Awar
d\, the Tau Beta Pi Excellence in Undergraduate Teaching Award\, and the G
ores Award for Excellence in Teaching\, Stanford’s highest teaching award.
He has been a Thomson Reuters Highly Cited Researcher since 2015
\, recognizing that he ranks in the top 1% cited researchers in his field.
\n
\n
Hosted by: Garry Gold\, M.D.
\nSponso
red by the PHIND Center and the Department of Radiology
\n
Ticke
ts: https://stanford.z
oom.us/webinar/register/2816249009305/WN_lUezgp98RMKzD7rC6oeRFg.
BODY>
X-TICKETS-URL:https://stanford.zoom.us/webinar/register/2816249009305/WN_lU
ezgp98RMKzD7rC6oeRFg
END:VEVENT
BEGIN:VEVENT
UID:ai1ec-1619@web.stanford.edu/group/radweb/cgi-bin/radcalendar
DTSTAMP:20240410T061457Z
CATEGORIES;LANGUAGE=en-US:PHIND\,PHIND Seminar Series
CONTACT:Ashley Williams\; ashleylw@stanford.edu\; https://med.stanford.edu/
phind/events/2021.html
DESCRIPTION:PHIND Seminar Series: Peace of mind for those affected by strok
e\nOrestis Vardoulis\, Ph.D.\nCo-Founder & CEO\nZeitMedical\n \nZoom Webin
ar Details\nWebinar URL: https://stanford.zoom.us/s/94427469356\nDial: US:
+1 650 724 9799 or +1 833 302 1536 (Toll Free)\nWebinar ID: 944 2746 935
6\nPasscode: 999031\n11:00am – 12:00pm Seminar & Discussion\n12:00pm – 12:
15pm Reception\nRSVP Here\n \nABSTRACT\nThere is a growing population of o
ver 10 million Americans that live with an elevated risk of having a strok
e.\nEach year approximately 1 million Americans survive a stroke or a mini
stroke\, often severely affected by its debilitating effects. A more disab
ling stroke frequently occurs after the seminal events\, leaving patients
and their families scarred for life.\nTIME = BRAIN. Early hospital present
ation is the most critical determinant in good stroke outcomes. However\,
most patients arrive at the hospital often hours after the event\, with le
ss than 10% receiving any form of treatment (thrombolysis / thrombectomy).
\nAs a result\, at risk individuals struggle daily with the fear\, a strok
e might happen during night-time or when they are alone. Unfortunately a s
troke that goes unnoticed for hours\, is most often not treatable due to t
he lack of salvageable tissue.\nTo alleviate that fear\, we are creating a
n AI-powered\, smart-headband that analyzes brain waves to detect the onse
t of an event immediately\, and alert the patient\, caregivers and 911.\nO
ur stroke detection AI has already been shown to detect ischemia during hi
gh-risk surgeries with 90% sensitivity and no false positives.\nWe have re
ceived FDA breakthrough designation for our solution and are currently run
ning a pilot human factors and signal quality study.\nOur vision is to pro
vide peace of mind and optimal brain health for everyone.\n \nABOUT\nOrest
is is the CEO and Co-founder of Zeit Medical\, a telehealth company that o
ffers at home monitoring and alert solutions for patients at risk for stro
ke. Prior to starting Zeit\, Orestis was a Stanford Biodesign Innovation F
ellow where his team developed the initial idea about at-home stroke detec
tion. Orestis trained as a Mechanical Engineer\, at Aristotle University\,
Greece\, earned his PhD in Biotechnology and Bioengineering at EPFL\, Swi
tzerland and conducted cutting edge research in flexible wearable electron
ics with the Bao Group at Stanford Chemical Engineering. He has authored m
ore than twenty publications in prestigious journals and has filed for a v
ariety of patents at the intersection of materials technology and medical
devices. Orestis currently lives in San Francisco\, where he also contribu
tes to the UCSF-Stanford pediatric device consortium as a technology advis
or. He also maintains close ties with the med-tech and health-tech commun
ities in Switzerland and Greece\, contributing to regional Biodesign educa
tional workshops.\n \nHosted by: Garry Gold\, M.D.\nSponsored by the PHIND
Center and the Department of Radiology\nTickets: https://stanford.zoom.us
/webinar/register/3016264733187/WN_i3dqwzHERYOfa7-Y87t7PQ.
DTSTART;TZID=America/Los_Angeles:20210817T110000
DTEND;TZID=America/Los_Angeles:20210817T120000
LOCATION:Zoom - See Description for Zoom Link
SEQUENCE:0
SUMMARY:PHIND Seminar – Orestis Vardoulis\, Ph.D.
URL:http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/event/phind-se
minar-orestis-vardoulis-ph-d/
X-COST-TYPE:external
X-WP-IMAGES-URL:thumbnail\;http://web.stanford.edu/group/radweb/cgi-bin/rad
calendar/wp-content/uploads/2019/10/ovardoulis_hshot_1-150x150.png\;150\;1
50\;1\,medium\;http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/wp
-content/uploads/2019/10/ovardoulis_hshot_1-300x300.png\;300\;300\;1\,larg
e\;http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/wp-content/upl
oads/2019/10/ovardoulis_hshot_1.png\;640\;640\;\,full\;http://web.stanford
.edu/group/radweb/cgi-bin/radcalendar/wp-content/uploads/2019/10/ovardouli
s_hshot_1.png\;716\;716\;
X-ALT-DESC;FMTTYPE=text/html:\\n\\n\\n
\\n\\n
PHIND Seminar Series: P
eace of mind for those affected by stroke
\n
Orestis Vardoulis\, Ph.D.
strong>
\nCo-Founder & CEO
\nZeitMedical
\n
\n
<
em>Zoom Webinar Details
\nWebinar URL: http
s://stanford.zoom.us/s/94427469356
\nDial: US: +1 650 724 9799 o
r +1 833 302 1536 (Toll Free)
\nWebinar ID: 944 2746 9356
\nPass
code: 999031
\n
11:00am – 12:00pm Seminar & Discussion
\n12:00pm
– 12:15pm Reception
\nRSVP Here
\n
\n
ABSTRACT
\n
There is a growing population of ov
er 10 million Americans that live with an elevated risk of having a stroke
.
\n
Each year approximately 1 million Americans survive a stroke or
a ministroke\, often severely affected by its debilitating effects. A more
disabling stroke frequently occurs after the seminal events\, leaving pat
ients and their families scarred for life.
\n
TIME = BRAIN. Early hos
pital presentation is the most critical determinant in good stroke outcome
s. However\, most patients arrive at the hospital often hours after the ev
ent\, with less than 10% receiving any form of treatment (thrombolysis / t
hrombectomy).
\n
As a result\, at risk individuals struggle daily wit
h the fear\, a stroke might happen during night-time or when they are alon
e. Unfortunately a stroke that goes unnoticed for hours\, is most often no
t treatable due to the lack of salvageable tissue.
\n
To alleviate th
at fear\, we are creating an AI-powered\, smart-headband that analyzes bra
in waves to detect the onset of an event immediately\, and alert the patie
nt\, caregivers and 911.
\n
Our stroke detection AI has already been
shown to detect ischemia during high-risk surgeries with 90% sensitivity a
nd no false positives.
\n
We have received FDA breakthrough designati
on for our solution and are currently running a pilot human factors and si
gnal quality study.
\n
Our vision is to provide peace of mind and opt
imal brain health for everyone.
\n
\n
ABOUT\nOrestis is the CEO and Co-founder of Zeit Medical\, a telehealth com
pany that offers at home monitoring and alert solutions for patients at ri
sk for stroke. Prior to starting Zeit\, Orestis was a Stanford Biodesign I
nnovation Fellow where his team developed the initial idea about at-home s
troke detection. Orestis trained as a Mechanical Engineer\, at Aristotle U
niversity\, Greece\, earned his PhD in Biotechnology and Bioengineering at
EPFL\, Switzerland and conducted cutting edge research in flexible wearab
le electronics with the Bao Group at Stanford Chemical Engineering. He has
authored more than twenty publications in prestigious journals and has fi
led for a variety of patents at the intersection of materials technology a
nd medical devices. Orestis currently lives in San Francisco\, where he al
so contributes to the UCSF-Stanford pediatric device consortium as a techn
ology advisor. He also maintains close ties with the med-tech and health-
tech communities in Switzerland and Greece\, contributing to regional Biod
esign educational workshops.
\n
\n
Hosted by: Garry Gold\,
M.D.
\nSponsored by the PHIND Center and the Department of
Radiology
\n
Tickets: https://stanford.zoom.us/webinar/register/3016264733187/WN_i3dqw
zHERYOfa7-Y87t7PQ.
X-TICKETS-URL:https://stanford.zoom.us/webinar/register/3016264733187/WN_i3
dqwzHERYOfa7-Y87t7PQ
END:VEVENT
BEGIN:VEVENT
UID:ai1ec-2851@web.stanford.edu/group/radweb/cgi-bin/radcalendar
DTSTAMP:20240410T061457Z
CATEGORIES;LANGUAGE=en-US:CME\,CME Radiology Grand Rounds\,Radiology
CONTACT:Tricia Hatcliff\; 650-498-7359\; thatcliff@stanford.edu
DESCRIPTION:CME Grand Rounds Sanjiv Sam Gambhir Lectureship – “Imaging at t
he Speed of Light: Innovations in Positron Emission Tomography”\n \nSimon
R. Cherry\, PhD\nProfessor\nBiomedical Engineering & Radiology\nUC Davis
\n \nJoin from PC\, Mac\, Linux\, iOS or Android: https://stanford.zoom.us
/j/600003703?pwd=RjcwS2MvOG1qVkxyL3U0RmNtUDVWdz09\nMeeting ID: 600 003 703
\nPassword: 566048\nOr iPhone one-tap (US Toll): +18333021536\,\,600003703
# or +16507249799\,\,600003703#\nOr Telephone:\nDial: +1 650 724 9799 (US\
, Canada\, Caribbean Toll) or +1 833 302 1536 (US\, Canada\, Caribbean Tol
l Free)\nInternational numbers available: https://stanford.zoom.us/u/acuqp
hnvqT\n \nABSTRACT\nPositron emission tomography (PET) allows for sensitiv
e and quantitative measurement of physiology\, metabolism and molecular ta
rgets noninvasively in the human body. However\, typical clinical PET sca
nners capture less than 1% of the available signal produced in the body.
PET scanners also are not currently capable of precisely determining the l
ocation at which a particular decay occurs. These limitations present oppo
rtunities for further innovation that ultimately will impact molecular ima
ging research and diagnostic imaging with PET. This presentation focuses
on 1) total-body PET imaging which greatly improves signal collection\, al
lowing radiotracer kinetics to be assessed across the entire human body fo
r the first time\, and 2) the development of detector technologies that ha
ve a timing precision of ~ 30 picoseconds\, enabling direct localization o
f radiotracer decays without tomographic reconstruction.\n \nBIO\nSimon R.
Cherry\, Ph.D. received his B.Sc.(Hons) in Physics with Astronomy from U
niversity College London in 1986 and a Ph.D. in Medical Physics from the I
nstitute of Cancer Research\, University of London in 1989. After a postd
octoral fellowship at UCLA\, he joined the faculty in the Department of Mo
lecular and Medical Pharmacology\, also at UCLA\, in 1993. In 2001\, Dr. C
herry joined UC Davis and established the Center for Molecular and Genomic
Imaging\, which he directed from 2004-2016. Currently Dr. Cherry is Disti
nguished Professor in the Departments of Biomedical Engineering and Radiol
ogy at UC Davis.\nDr. Cherry’s research interests center around biomedical
imaging and in particular the development and application of in vivo mole
cular imaging systems. His major accomplishments have been in developing
systems for positron emission tomography (PET)\, in particular the inventi
on of the microPET technology that was subsequently widely adopted in acad
emia and industry and as co-leader of the EXPLORER consortium which has de
veloped the world’s first total-body PET scanner. He also has contributed
to detector technology innovations for PET\, conducted early biomedical s
tudies using Cerenkov luminescence\, and developed the first proof-of-conc
ept hybrid PET/MRI (magnetic resonance imaging) systems.\nDr. Cherry is a
founding member of the Society of Molecular Imaging and an elected fellow
of six professional societies\, including the Institute for Electronic and
Electrical Engineers (IEEE) and the Biomedical Engineering Society (BMES)
. He served as Editor-in-Chief of the journal Physics in Medicine and Biol
ogy from 2011-2020. Dr. Cherry received the Academy of Molecular Imaging D
istinguished Basic Scientist Award (2007)\, the Society for Molecular Imag
ing Achievement Award (2011) and the IEEE Marie Sklodowska-Curie Award (20
16). In 2016\, he was elected as a member of the National Academy of Eng
ineering and in 2017 he was elected to the National Academy of Inventors.
Dr. Cherry is the author of more than 240 peer-reviewed journal articles\
, review articles and book chapters in the field of biomedical imaging. He
is also lead author of the widely-used textbook “Physics in Nuclear Medic
ine”.
DTSTART;TZID=America/Los_Angeles:20210910T120000
DTEND;TZID=America/Los_Angeles:20210910T130000
LOCATION:LKSC 101/102 & Zoom - See Description for Zoom Link @ 291 Campus D
rive\, Stanford\, CA 94305
SEQUENCE:0
SUMMARY:CME Grand Rounds Sanjiv Sam Gambhir Lectureship – Simon Cherry\, Ph
D
URL:http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/event/cme-gran
d-rounds-sanjiv-sam-gambhir-lectureship-simon-cherry-phd/
X-COST-TYPE:free
X-WP-IMAGES-URL:thumbnail\;http://web.stanford.edu/group/radweb/cgi-bin/rad
calendar/wp-content/uploads/2021/07/simon_cherry_website-150x150.jpg\;150\
;150\;1\,medium\;http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/
wp-content/uploads/2021/07/simon_cherry_website-269x300.jpg\;269\;300\;1\,
large\;http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/wp-content
/uploads/2021/07/simon_cherry_website.jpg\;520\;580\;
X-ALT-DESC;FMTTYPE=text/html:\\n\\n\\n
\\n\\n
CME Grand Rounds Sanjiv S
am Gambhir Lectureship – “Imaging at the Speed of Light: Innovations
in Positron Emission Tomography”
\n
\n
Simon R. C
herry\, PhD
\nProfessor
\nBiomedical Engineering & Radi
ology
\nUC Davis
\n
\n
Join from PC\, Mac\, Linux\, iOS o
r Android: https://stanford.zoom.us/j/600003703?pwd=RjcwS2MvOG1q
VkxyL3U0RmNtUDVWdz09
\nMeeting ID: 600 003 703
\nPassword: 5
66048
\nOr iPhone one-tap (US Toll): +18333021536\,\,600003703# or +1
6507249799\,\,600003703#
\nOr Telephone:
\nDial: +1 650 724 9799
(US\, Canada\, Caribbean Toll) or +1 833 302 1536 (US\, Canada\, Caribbea
n Toll Free)
\nInternational numbers available: https://stanford.zoom.us/u/acuqphnvqT
\n
\n
ABSTRACT
\n
Positron emission tomograph
y (PET) allows for sensitive and quantitative measurement of physiology\,
metabolism and molecular targets noninvasively in the human body. However
\, typical clinical PET scanners capture less than 1% of the available sig
nal produced in the body. PET scanners also are not currently capable of
precisely determining the location at which a particular decay occurs. The
se limitations present opportunities for further innovation that ultimatel
y will impact molecular imaging research and diagnostic imaging with PET.
This presentation focuses on 1) total-body PET imaging which greatly impr
oves signal collection\, allowing radiotracer kinetics to be assessed acro
ss the entire human body for the first time\, and 2) the development of de
tector technologies that have a timing precision of ~ 30 picoseconds\, ena
bling direct localization of radiotracer decays without tomographic recons
truction.
\n
\n
BIO
\n
Simon R. Cherry\,
Ph.D. received his B.Sc.(Hons) in Physics with Astronomy from University
College London in 1986 and a Ph.D. in Medical Physics from the Institute
of Cancer Research\, University of London in 1989. After a postdoctoral f
ellowship at UCLA\, he joined the faculty in the Department of Molecular a
nd Medical Pharmacology\, also at UCLA\, in 1993. In 2001\, Dr. Cherry joi
ned UC Davis and established the Center for Molecular and Genomic Imaging\
, which he directed from 2004-2016. Currently Dr. Cherry is Distinguished
Professor in the Departments of Biomedical Engineering and Radiology at UC
Davis.
\n
Dr. Cherry’s research interests center around biomedical i
maging and in particular the development and application of in vivo molecu
lar imaging systems. His major accomplishments have been in developing sy
stems for positron emission tomography (PET)\, in particular the invention
of the microPET technology that was subsequently widely adopted in academ
ia and industry and as co-leader of the EXPLORER consortium which has deve
loped the world’s first total-body PET scanner. He also has contributed t
o detector technology innovations for PET\, conducted early biomedical stu
dies using Cerenkov luminescence\, and developed the first proof-of-concep
t hybrid PET/MRI (magnetic resonance imaging) systems.
\n
Dr. Cherry
is a founding member of the Society of Molecular Imaging and an elected fe
llow of six professional societies\, including the Institute for Electroni
c and Electrical Engineers (IEEE) and the Biomedical Engineering Society (
BMES). He served as Editor-in-Chief of the journal Physics in Medicine and
Biology from 2011-2020. Dr. Cherry received the Academy of Molecular Imag
ing Distinguished Basic Scientist Award (2007)\, the Society for Molecular
Imaging Achievement Award (2011) and the IEEE Marie Sklodowska-Curie Awar
d (2016). In 2016\, he was elected as a member of the National Academy o
f Engineering and in 2017 he was elected to the National Academy of Invent
ors. Dr. Cherry is the author of more than 240 peer-reviewed journal arti
cles\, review articles and book chapters in the field of biomedical imagin
g. He is also lead author of the widely-used textbook “Physics in Nuclear
Medicine”.
\n
END:VEVENT
BEGIN:VEVENT
UID:ai1ec-1645@web.stanford.edu/group/radweb/cgi-bin/radcalendar
DTSTAMP:20240410T061457Z
CATEGORIES;LANGUAGE=en-US:PHIND\,PHIND Seminar Series
CONTACT:Ashley Williams\; ashleylw@stanford.edu
DESCRIPTION:PHIND Seminar Series: Towards precision diagnostic and predicti
on of food allergy\nSindy KY Tang\, Ph.D.\nAssociate Professor of Mechanic
al Engineering\, Senior Fellow at the Woods Institute for the Environment
and Professor\, by courtesy\, of Radiology – PHIND Center\nStanford Univer
sity\n \nLocation: Zoom\nWebinar URL: https://stanford.zoom.us/s/919329663
34\nDial: US: +1 650 724 9799 or +1 833 302 1536 (Toll Free)\nWebinar ID:
919 3296 6334\nPasscode: 383071\n11:00am – 12:00pm Seminar & Discussion\n
RSVP Here\n \nABSTRACT\nFood allergy has reached epidemic proportions. Acc
urate in vitro methods that are efficient and easy to use to identify offe
nding food allergens are lacking. Oral food challenge\, the gold standard
for food allergy assessment\, is often not performed as it places the pati
ent at risk of anaphylaxis. As such\, food allergy is often identified onl
y after an adverse reaction that could be life-threatening. Our long-term
goal is to develop a food allergy diagnostic test that is accurate\, safe\
, rapid\, and accessible\, so that food allergy can be easily identified p
rior to the occurrence of an adverse reaction\, and that the efficacy of i
mmunotherapy for food allergy can be tracked more effectively. This talk w
ill discuss our recent work on developing such a test. Our approach is bas
ed on the Basophil Activation Test (BAT)\, which measures the activation o
f basophils in whole blood after stimulation with specific food allergens
ex vivo. The BAT has been shown to be highly predictive of allergic reacti
ons. However\, the need for flow cytometry has limited its broader use. We
are developing a miniaturized\, standalone version of the BAT. We envisio
n that the test can be used at the point of care\, such as the doctor’s of
fice or at a local pharmacy.\n \nABOUT\nProf. Sindy KY Tang is the Kenneth
and Barbara Oshman Faculty Scholar and Associate Professor of Mechanical
Engineering and by courtesy of Radiology (Precision Health and Integrated
Diagnostics) at Stanford University. She received her Ph.D. from Harvard U
niversity in Engineering Sciences under the supervision of Prof. George Wh
itesides. Her lab at Stanford works on the fundamental understanding of fl
uid mechanics and mass transport in micro-nano systems\, and the applicati
on of this knowledge towards problems in biology\, rapid diagnostics for h
ealth and environmental sustainability. The current areas of focus include
the flow physics of confined micro-droplets using experimental and machin
e learning methods\, interfacial mass transport and self-assembly\, and ul
trahigh throughput opto-microfluidic systems for disease diagnostics\, wat
er and energy sustainability\, and single-cell wound healing studies. She
was a Stanford Biodesign Faculty Fellow in 2018. Dr. Tang’s work has been
recognized by multiple awards including the NSF CAREER Award\, 3M Nontenur
ed Faculty Award\, the ACS Petroleum Fund New Investigator Award\, and inv
ited lecture at the Nobel Symposium on Microfluidics in Sweden. Website: h
ttp://web.stanford.edu/group/tanglab/\n \nHosted by: Garry Gold\, M.D.\nSp
onsored by the PHIND Center and the Department of Radiology\nTickets: http
s://stanford.zoom.us/webinar/register/1216286302579/WN_3iFMsumAT9iKlV5G1Vr
9zA.
DTSTART;TZID=America/Los_Angeles:20210921T110000
DTEND;TZID=America/Los_Angeles:20210921T120000
LOCATION:Zoom - See Description for Zoom Link
SEQUENCE:0
SUMMARY:PHIND Seminar – Sindy KY Tang\, Ph.D.
URL:http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/event/phind-se
minar-sindy-ky-tang-ph-d/
X-COST-TYPE:external
X-WP-IMAGES-URL:thumbnail\;http://web.stanford.edu/group/radweb/cgi-bin/rad
calendar/wp-content/uploads/2019/10/sindy-tang_profilephoto-150x150.jpg\;1
50\;150\;1\,medium\;http://web.stanford.edu/group/radweb/cgi-bin/radcalend
ar/wp-content/uploads/2019/10/sindy-tang_profilephoto-300x300.jpg\;300\;30
0\;1\,large\;http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/wp-c
ontent/uploads/2019/10/sindy-tang_profilephoto.jpg\;350\;350\;
X-ALT-DESC;FMTTYPE=text/html:\\n\\n\\n
\\n\\n
PHIND Seminar Series:
Towards precision diagnostic and prediction of food allergy
\n
Sindy KY Tan
g\, Ph.D.
\nAssociate Professor of Mechanical Engineerin
g\, Senior Fellow at the Woods Institute for the Environment and Professor
\, by courtesy\, of Radiology – PHIND Center
\nStanford University
\n
\n
Location: Zoom
\nWebinar URL: https://stanford.zoom.us/s/91932966334
\nDial: US: +1
650 724 9799 or +1 833 302 1536 (Toll Free)
\nWebinar ID: 919 3296 6
334
\nPasscode: 383071
\n
11:00am – 12:00pm Seminar & Discussion
\nRSVP Here
\n
\n
ABSTRACT
\nFood allergy has reached epidemic proportions. Accurate i
n vitro methods that are efficient and easy to use to identify offending f
ood allergens are lacking. Oral food challenge\, the gold standard for foo
d allergy assessment\, is often not performed as it places the patient at
risk of anaphylaxis. As such\, food allergy is often identified only after
an adverse reaction that could be life-threatening. Our long-term goal is
to develop a food allergy diagnostic test that is accurate\, safe\, rapid
\, and accessible\, so that food allergy can be easily identified prior to
the occurrence of an adverse reaction\, and that the efficacy of immunoth
erapy for food allergy can be tracked more effectively. This talk will dis
cuss our recent work on developing such a test. Our approach is based on t
he Basophil Activation Test (BAT)\, which measures the activation of basop
hils in whole blood after stimulation with specific food allergens ex vivo
. The BAT has been shown to be highly predictive of allergic reactions. Ho
wever\, the need for flow cytometry has limited its broader use. We are de
veloping a miniaturized\, standalone version of the BAT. We envision that
the test can be used at the point of care\, such as the doctor’s office or
at a local pharmacy.
\n
\n
ABOUT
\nProf
. Sindy KY Tang is the Kenneth and Barbara Oshman Faculty Scholar and Asso
ciate Professor of Mechanical Engineering and by courtesy of Radiology (Pr
ecision Health and Integrated Diagnostics) at Stanford University. She rec
eived her Ph.D. from Harvard University in Engineering Sciences under the
supervision of Prof. George Whitesides. Her lab at Stanford works on the f
undamental understanding of fluid mechanics and mass transport in micro-na
no systems\, and the application of this knowledge towards problems in bio
logy\, rapid diagnostics for health and environmental sustainability. The
current areas of focus include the flow physics of confined micro-droplets
using experimental and machine learning methods\, interfacial mass transp
ort and self-assembly\, and ultrahigh throughput opto-microfluidic systems
for disease diagnostics\, water and energy sustainability\, and single-ce
ll wound healing studies. She was a Stanford Biodesign Faculty Fellow in 2
018. Dr. Tang’s work has been recognized by multiple awards including the
NSF CAREER Award\, 3M Nontenured Faculty Award\, the ACS Petroleum Fund Ne
w Investigator Award\, and invited lecture at the Nobel Symposium on Micro
fluidics in Sweden. Website: http://web.stanford.edu/group/tanglab/
\n
\n
Hoste
d by: Garry Gold\, M.D.
\nSponsored by the PHIND Center and
the Department of Radiology
\n
Tickets: https://stanford.zoom.us/webinar/register/1216
286302579/WN_3iFMsumAT9iKlV5G1Vr9zA.
X-TICKETS-URL:https://stanford.zoom.us/webinar/register/1216286302579/WN_3i
FMsumAT9iKlV5G1Vr9zA
END:VEVENT
BEGIN:VEVENT
UID:ai1ec-2575@web.stanford.edu/group/radweb/cgi-bin/radcalendar
DTSTAMP:20240410T061457Z
CATEGORIES;LANGUAGE=en-US:MIPS\,MIPS Seminar
CONTACT:Ashley Williams\; ashleylw@stanford.edu\; https://med.stanford.edu/
mips/events.html
DESCRIPTION:MIPS Seminar Series: Predicting and Preventing Fetal and Neonat
al Pathology: Looking Back and Looking Forward\nDavid K. Stevenson\, MD\nT
he Harold K. Faber Professor of Pediatrics\, Senior Associate Dean\, Mater
nal and Child Health and Professor\, by courtesy\, of Obstetrics and Gynec
ology\nLucile Packard Children’s Hospital\n \nZoom Webinar Details\nWebina
r URL: https://stanford.zoom.us/s/94584828060\nDial: +1 650 724 9799 or +1
833 302 1536\nWebinar ID: 945 8482 8060\nPasscode: 481874\n12:00pm – 12:4
5pm Seminar & Discussion\nRSVP Here\n \nABSTRACT\nThe importance of minima
lly invasive technologies for interrogating the fetus and newborn\, as wel
l as of knowing where a biologic system is headed\, not just where it has
been\, when trying to predict and prevent acquired diseases\, will be disc
ussed. Examples of such technologies\, such as trace gas analysis and opt
ical reporting of biologic phenomena\, and their application to model syst
ems and the human newborn will be presented. The role of advanced computa
tional approaches for the integration and interpretation of large amounts
of data derived from these new measurement tools will be emphasized.\n \nA
BOUT\nDr. David K. Stevenson is the Harold K. Faber Professor of Pediatric
s and has made many impactful contributions to the field of neonatology an
d pediatrics\, including his seminal studies on neonatal jaundice\, biliru
bin production and heme oxygenase biology. As a neonatologist\, his resea
rch has focused primarily on neonatal jaundice and more recently on the ca
uses of preterm birth and its prevention. He has held numerous leadership
roles at Stanford University School of Medicine\, including Vice Dean and
Senior Associate Dean for Academic Affairs. He is currently the Senior As
sociate Dean for Maternal & Child Health\, the Co-Director of the Stanford
Maternal & Child Health Research Institute\, and the Principal Investigat
or for the March of Dimes Prematurity Research Center at Stanford Universi
ty. Dr. Stevenson has received many awards\, including the Virginia Apgar
Award\, which is the highest award in Perinatal Pediatrics\, the Joseph W
. St. Geme\, Jr. Leadership Award from the Federation of Pediatric Organiz
ations\, the Jonas Salk Award for Leadership in Prematurity Prevention fro
m the March of Dimes Foundation\, and the John Howland Medal and Award\, t
he highest award in academic pediatrics. He has served as the President o
f the American Pediatric Society. In recognition of his achievements\, Dr.
Stevenson is a member of the National Academy of Medicine.\n \nHosted by:
Katherine Ferrara\, PhD\nSponsored by: Molecular Imaging Program at Stanf
ord & the Department of Radiology\nTickets: https://stanford.zoom.us/webin
ar/register/7116294064170/WN_H60DZOKZSlWC6UBOB3FTVw.
DTSTART;TZID=America/Los_Angeles:20210923T120000
DTEND;TZID=America/Los_Angeles:20210923T124500
LOCATION:Zoom - See Description for Zoom Link
SEQUENCE:0
SUMMARY:MIPS Seminar – David K. Stevenson\, MD
URL:http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/event/mips-sem
inar-david-k-stevenson-md/
X-COST-TYPE:external
X-WP-IMAGES-URL:thumbnail\;http://web.stanford.edu/group/radweb/cgi-bin/rad
calendar/wp-content/uploads/2019/10/david-stevenson_profilephoto-150x150.j
pg\;150\;150\;1\,medium\;http://web.stanford.edu/group/radweb/cgi-bin/radc
alendar/wp-content/uploads/2019/10/david-stevenson_profilephoto-300x300.jp
g\;300\;300\;1\,large\;http://web.stanford.edu/group/radweb/cgi-bin/radcal
endar/wp-content/uploads/2019/10/david-stevenson_profilephoto.jpg\;350\;35
0\;
X-ALT-DESC;FMTTYPE=text/html:\\n\\n\\n
\\n\\n
MIPS Semi
nar Series: Predicting and Preventing Fetal and Neonatal Path
ology: Looking Back and Looking Forward
\n
David K. Stevenson\, MD
\nThe
Harold K. Faber Professor of Pediatrics\, Senior Associate Dean\, Maternal
and Child Health and Professor\, by courtesy\, of Obstetrics and Gynecolo
gy
\nLucile Packard Children’s Hospital
\n
\n
Zoom Webinar Details
\nWebinar URL: https://stanfo
rd.zoom.us/s/94584828060
\nDial: +1 650 724 9799 or +1 833 302 15
36
\nWebinar ID: 945 8482 8060
\nPasscode: 481874
\n
12:00p
m – 12:45pm Seminar & Discussion
\nRSVP Here
\n
\n
ABSTRACT
\nThe importance of minimal
ly invasive technologies for interrogating the fetus and newborn\, as well
as of knowing where a biologic system is headed\, not just where it has b
een\, when trying to predict and prevent acquired diseases\, will be discu
ssed. Examples of such technologies\, such as trace gas analysis and opti
cal reporting of biologic phenomena\, and their application to model syste
ms and the human newborn will be presented. The role of advanced computat
ional approaches for the integration and interpretation of large amounts o
f data derived from these new measurement tools will be emphasized.
\n<
p> \n
ABOUT
\nDr. David K. Stevenson is the Ha
rold K. Faber Professor of Pediatrics and has made many impactful contribu
tions to the field of neonatology and pediatrics\, including his seminal s
tudies on neonatal jaundice\, bilirubin production and heme oxygenase biol
ogy. As a neonatologist\, his research has focused primarily on neonatal
jaundice and more recently on the causes of preterm birth and its preventi
on. He has held numerous leadership roles at Stanford University School o
f Medicine\, including Vice Dean and Senior Associate Dean for Academic Af
fairs. He is currently the Senior Associate Dean for Maternal & Child Heal
th\, the Co-Director of the Stanford Maternal & Child Health Research Inst
itute\, and the Principal Investigator for the March of Dimes Prematurity
Research Center at Stanford University. Dr. Stevenson has received many a
wards\, including the Virginia Apgar Award\, which is the highest award in
Perinatal Pediatrics\, the Joseph W. St. Geme\, Jr. Leadership Award from
the Federation of Pediatric Organizations\, the Jonas Salk Award for Lead
ership in Prematurity Prevention from the March of Dimes Foundation\, and
the John Howland Medal and Award\, the highest award in academic pediatric
s. He has served as the President of the American Pediatric Society. In r
ecognition of his achievements\, Dr. Stevenson is a member of the National
Academy of Medicine.
\n
\n
Hosted by: Katherine Ferrara\,
PhD
\nSponsored by: Molecular Imaging Program at Stanford &
the Department of Radiology
\n
Tickets: https://stanford.zoom.us/webinar/register/711
6294064170/WN_H60DZOKZSlWC6UBOB3FTVw.
X-TICKETS-URL:https://stanford.zoom.us/webinar/register/7116294064170/WN_H6
0DZOKZSlWC6UBOB3FTVw
END:VEVENT
BEGIN:VEVENT
UID:ai1ec-2885@web.stanford.edu/group/radweb/cgi-bin/radcalendar
DTSTAMP:20240410T061457Z
CATEGORIES;LANGUAGE=en-US:CME\,CME Radiology Grand Rounds\,Radiology
CONTACT:Tricia Hatcliff\; 650-498-7359\; thatcliff@stanford.edu
DESCRIPTION:CME Grand Rounds Diversity Lectureship – Topic: TBD\n \nJennife
r L. Eberhardt\, PhD\nProfessor\nPsychology\nStanford University\n \nJoin
from PC\, Mac\, Linux\, iOS or Android: https://stanford.zoom.us/j/6000037
03?pwd=RjcwS2MvOG1qVkxyL3U0RmNtUDVWdz09\nMeeting ID: 600 003 703\nPassword
: 566048\nOr iPhone one-tap (US Toll): +18333021536\,\,600003703# or +1650
7249799\,\,600003703#\nOr Telephone:\nDial: +1 650 724 9799 (US\, Canada\,
Caribbean Toll) or +1 833 302 1536 (US\, Canada\, Caribbean Toll Free)\nI
nternational numbers available: https://stanford.zoom.us/u/acuqphnvqT\n \n
ABSTRACT\nComing soon!\n \nBIO\nComing soon!
DTSTART;TZID=America/Los_Angeles:20210924T120000
DTEND;TZID=America/Los_Angeles:20210924T130000
LOCATION:Zoom - See Description for Zoom Link
SEQUENCE:0
SUMMARY:CME Grand Rounds Diversity Lectureship – Jennifer L. Eberhardt\, Ph
D
URL:http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/event/cme-gran
d-rounds-diversity-lectureship-jennifer-l-eberhardt-phd/
X-COST-TYPE:free
X-WP-IMAGES-URL:thumbnail\;http://web.stanford.edu/group/radweb/cgi-bin/rad
calendar/wp-content/uploads/2021/07/download-150x150.jpg\;150\;150\;1\,med
ium\;http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/wp-content/u
ploads/2021/07/download.jpg\;214\;236\;
X-ALT-DESC;FMTTYPE=text/html:\\n\\n\\n
\\n\\n
CME Grand Rounds Diversity Lectureship –
Topic: TBD
\n
\n
Jennifer L. Eberhardt\, PhD
\nProfessor
\nPsychology
\nStanford University
\n
\n
Join from PC\, Mac\, Linux\, iOS or Android: https://
stanford.zoom.us/j/600003703?pwd=RjcwS2MvOG1qVkxyL3U0RmNtUDVWdz09
\nMeeting ID: 600 003 703
\nPassword: 566048
\nOr iPhone one-ta
p (US Toll): +18333021536\,\,600003703# or +16507249799\,\,600003703#
\nOr Telephone:
\nDial: +1 650 724 9799 (US\, Canada\, Caribbean Tol
l) or +1 833 302 1536 (US\, Canada\, Caribbean Toll Free)
\nInternati
onal numbers available: ht
tps://stanford.zoom.us/u/acuqphnvqT
\n
\n
ABSTRACT
\nComing soon!
\n
\n
BIO
\nComing soon!
\n
END:VEVENT
BEGIN:VEVENT
UID:ai1ec-2903@web.stanford.edu/group/radweb/cgi-bin/radcalendar
DTSTAMP:20240410T061457Z
CATEGORIES;LANGUAGE=en-US:CME\,CME Radiology Grand Rounds\,Radiology
CONTACT:Tricia Hatcliff\; 650-498-7359\; thatcliff@stanford.edu
DESCRIPTION:CME Grand Rounds – “Community Based Partnered Research: Revisi
ting a Critical Concept for Radiology”\n \nChristoph L. Lee\, MD\, MS\, MB
A\nProfessor\nRadiology\nUniversity of Washington\n \nJoin from PC\, Mac\,
Linux\, iOS or Android: https://stanford.zoom.us/j/600003703?pwd=RjcwS2Mv
OG1qVkxyL3U0RmNtUDVWdz09\nMeeting ID: 600 003 703\nPassword: 566048\nOr iP
hone one-tap (US Toll): +18333021536\,\,600003703# or +16507249799\,\,6000
03703#\nOr Telephone:\nDial: +1 650 724 9799 (US\, Canada\, Caribbean Toll
) or +1 833 302 1536 (US\, Canada\, Caribbean Toll Free)\nInternational nu
mbers available: https://stanford.zoom.us/u/acuqphnvqT\n \nABSTRACT\nComin
g soon!\n \nBIO\nComing soon!
DTSTART;TZID=America/Los_Angeles:20211008T120000
DTEND;TZID=America/Los_Angeles:20211008T130000
LOCATION:Zoom - See Description for Zoom Link
SEQUENCE:0
SUMMARY:CME Grand Rounds – Christoph L. Lee\, MD\, MS\, MBA
URL:http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/event/cme-gran
d-rounds-christoph-l-lee-md-ms-mba/
X-COST-TYPE:free
X-WP-IMAGES-URL:thumbnail\;http://web.stanford.edu/group/radweb/cgi-bin/rad
calendar/wp-content/uploads/2021/07/C-Lee2017_2-214x300-150x150.jpg\;150\;
150\;1\,medium\;http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/w
p-content/uploads/2021/07/C-Lee2017_2-214x300-214x300.jpg\;214\;300\;1
X-ALT-DESC;FMTTYPE=text/html:\\n\\n\\n
\\n\\n
CME Grand Rounds – “Commun
ity Based Partnered Research: Revisiting a Critical Concept for Radiology
”
\n
\n
Christoph L. Lee\, MD\, MS\, MBA
\nProfessor
\nRadiology
\nUniversity of Washington
\n
\n
Join from PC\, Mac\, Linux\, iOS or Android: https://stanf
ord.zoom.us/j/600003703?pwd=RjcwS2MvOG1qVkxyL3U0RmNtUDVWdz09
\nMe
eting ID: 600 003 703
\nPassword: 566048
\nOr iPhone one-tap (US
Toll): +18333021536\,\,600003703# or +16507249799\,\,600003703#
\nOr
Telephone:
\nDial: +1 650 724 9799 (US\, Canada\, Caribbean Toll) or
+1 833 302 1536 (US\, Canada\, Caribbean Toll Free)
\nInternational
numbers available: https:/
/stanford.zoom.us/u/acuqphnvqT
\n
\n
ABSTRACT
\nComing soon!
\n
\n
BIO
\nCom
ing soon!
\n
END:VEVENT
BEGIN:VEVENT
UID:ai1ec-2295@web.stanford.edu/group/radweb/cgi-bin/radcalendar
DTSTAMP:20240410T061457Z
CATEGORIES;LANGUAGE=en-US:Canary Center\,Early Cancer Detection Seminar Ser
ies
CONTACT:Ashley Williams\; ashleylw@stanford.edu\; https://canarycenter.stan
ford.edu/seminars.html
DESCRIPTION:CEDSS: The First Cell: A new model for cancer research and trea
tment\nAzra Raza\, M.D.\nChan Soon-Shiong Professor of Medicine\nDirector\
, Myelodysplastic Syndrome Center\nColumbia University Medical Center\n \n
Location: Zoom\nMeeting URL: https://stanford.zoom.us/s/99340345860\nDial:
US: +1 650 724 9799 or +1 833 302 1536 (Toll Free)\nMeeting ID: 993 4034
5860\nPasscode: 711508\nRSVP Here\n \nABSTRACT\nCancer research continues
to be predicated on a 1970’s model of research and treatment. Despite hal
f a century of intense research\, we are failing spectacularly to improve
the outcome for patients with advanced disease. Those who are cured contin
ue to be treated mostly with the older strategies (surgery-chemo-radiation
). Our contention is that the real solution to the cancer problem is to di
agnose cancer early\, at the stage of The First Cell. The rapidly evolving
technologies are doing much in this area but need to be expanded. We stud
y a pre-leukemic condition called myelodysplastic syndrome (MDS) with the
hope that we can detect the first leukemia cells as the disease transforms
to acute myeloid leukemia (AML). Towards this end\, we have collected blo
od and bone marrow samples on MDS and AML patients since 1984. Today\, our
Tissue Repository has more than 60\,000 samples. We propose novel methods
to identify surrogate markers that can identify the First Cell through st
udying the serial samples of patients who evolve from MDS to AML.\n \nABOU
T\nDr. Raza is a Professor of Medicine and Director of the MDS Center at C
olumbia University in New York\, NY.She started her research in Myelodispl
astic Syndromes (MDS) in 1982 and moved to Rush University\, Chicago\, Ill
inois in 1992\, where she was the Charles Arthur Weaver Professor in Oncol
ogy and Director\, Division of Myeloid Diseases. The MDS Program\, along w
ith a Tissue Repository containing more than 50\,000 samples from MDS and
acute leukemia patients was successfully relocated to the University of Ma
ssachusetts in 2004 and to Columbia University in 2010.\nBefore moving to
New York\, Dr. Raza was the Chief of Hematology Oncology and the Gladys Sm
ith Martin Professor of Oncology at the University of Massachussetts in Wo
rcester. She has published the results of her laboratory research and clin
ical trials in prestigious\, peer reviewed journals such as The New Englan
d Journal of Medicine\, Nature\, Blood\, Cancer\, Cancer Research\, Britis
h Journal of Hematology\, Leukemia\, and Leukemia Research. Dr. Raza serve
s on numerous national and international panels as a reviewer\, consultant
and advisor and is the recipient of a number of awards.\n \nHosted by: Ut
kan Demirci\, Ph.D.\nSponsored by: The Canary Center & the Department of R
adiology \nStanford University – School of Medicine
DTSTART;TZID=America/Los_Angeles:20211012T110000
DTEND;TZID=America/Los_Angeles:20211012T120000
LOCATION:Venue coming soon!
SEQUENCE:0
SUMMARY:Cancer Early Detection Seminar Series – Azra Raza\, MD
URL:http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/event/cancer-e
arly-detection-seminar-series-azra-raza-md/
X-COST-TYPE:free
X-WP-IMAGES-URL:thumbnail\;http://web.stanford.edu/group/radweb/cgi-bin/rad
calendar/wp-content/uploads/2019/10/A_Raza-150x150.png\;150\;150\;1\,mediu
m\;http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/wp-content/upl
oads/2019/10/A_Raza-300x200.png\;300\;200\;1\,large\;http://web.stanford.e
du/group/radweb/cgi-bin/radcalendar/wp-content/uploads/2019/10/A_Raza.png\
;640\;426\;\,full\;http://web.stanford.edu/group/radweb/cgi-bin/radcalenda
r/wp-content/uploads/2019/10/A_Raza.png\;700\;466\;
X-ALT-DESC;FMTTYPE=text/html:\\n\\n\\n
\\n\\n
CEDSS: The First Cell: A new model
for cancer research and treatment
\n
Azra Raza\, M.D.
\nChan
Soon-Shiong Professor of Medicine
\nDirector\, Myelodysplastic Syndro
me Center
\nColumbia University Medical Center
\n
\n
L
ocation: Zoom
\nMeeting URL: https:
//stanford.zoom.us/s/99340345860
\nDial: US: +1 650 724 9799 or
+1 833 302 1536 (Toll Free)
\nMeeting ID: 993 4034 5860
\nPassco
de: 711508
\n
RSVP Here
\n<
p> \n
ABSTRACT
\n
Cancer research continues to
be predicated on a 1970’s model of research and treatment. Despite half a
century of intense research\, we are failing spectacularly to improve the
outcome for patients with advanced disease. Those who are cured continue
to be treated mostly with the older strategies (surgery-chemo-radiation).
Our contention is that the real solution to the cancer problem is to diagn
ose cancer early\, at the stage of The First Cell. The rapidly evolving te
chnologies are doing much in this area but need to be expanded. We study a
pre-leukemic condition called myelodysplastic syndrome (MDS) with the hop
e that we can detect the first leukemia cells as the disease transforms to
acute myeloid leukemia (AML). Towards this end\, we have collected blood
and bone marrow samples on MDS and AML patients since 1984. Today\, our Ti
ssue Repository has more than 60\,000 samples. We propose novel methods to
identify surrogate markers that can identify the First Cell through study
ing the serial samples of patients who evolve from MDS to AML.
\n
p>\n
ABOUT
\n
Dr. Raza is a Professor of Medicine
and Director of the MDS Center at Columbia University in New York\, NY.She
started her research in Myelodisplastic Syndromes (MDS) in 1982 and moved
to Rush University\, Chicago\, Illinois in 1992\, where she was the Charl
es Arthur Weaver Professor in Oncology and Director\, Division of Myeloid
Diseases. The MDS Program\, along with a Tissue Repository containing more
than 50\,000 samples from MDS and acute leukemia patients was successfull
y relocated to the University of Massachusetts in 2004 and to Columbia Uni
versity in 2010.
\n
Before moving to New York\, Dr. Raza was the Chie
f of Hematology Oncology and the Gladys Smith Martin Professor of Oncology
at the University of Massachussetts in Worcester. She has published the r
esults of her laboratory research and clinical trials in prestigious\, pee
r reviewed journals such as The New England Journal of Medicine\, Nature\,
Blood\, Cancer\, Cancer Research\, British Journal of Hematology\, Leukem
ia\, and Leukemia Research. Dr. Raza serves on numerous national and inter
national panels as a reviewer\, consultant and advisor and is the recipien
t of a number of awards.
\n
\n
Hosted by: Utkan Demirci\,
Ph.D.
\nSponsored by: Th
e Canary Center & the Department of Radiology
\nStanford Un
iversity – School of Medicine
\n
END:VEVENT
BEGIN:VEVENT
UID:ai1ec-1673@web.stanford.edu/group/radweb/cgi-bin/radcalendar
DTSTAMP:20240410T061457Z
CATEGORIES;LANGUAGE=en-US:PHIND\,PHIND Seminar Series
CONTACT:Ashley Williams\; ashleylw@stanford.edu
DESCRIPTION:PHIND Seminar Series: Topic TBA\nChristina Curtis\, Ph.D.\nAsso
ciate Professor of Medicine (Oncology) and of Genetics\nStanford Universit
y\n \nLocation: Venue coming soon!\n11:00am – 12:00pm Seminar & Discussion
\n12:00pm – 12:15pm Reception\nRSVP coming soon!\n \nABSTRACT\nComing soon
!\n \nABOUT\nComing soon!\n \nHosted by: Garry Gold\, M.D.\nSponsored by t
he PHIND Center and the Department of Radiology
DTSTART;TZID=America/Los_Angeles:20211019T110000
DTEND;TZID=America/Los_Angeles:20211019T120000
LOCATION:Venue coming soon!
SEQUENCE:0
SUMMARY:PHIND Seminar – Christina Curtis\, Ph.D.
URL:http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/event/phind-se
minar-christina-curtis-ph-d/
X-COST-TYPE:free
X-WP-IMAGES-URL:thumbnail\;http://web.stanford.edu/group/radweb/cgi-bin/rad
calendar/wp-content/uploads/2019/10/image.img_.320.high_-150x150.jpg\;150\
;150\;1\,medium\;http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/
wp-content/uploads/2019/10/image.img_.320.high_-234x300.jpg\;234\;300\;1\,
large\;http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/wp-content
/uploads/2019/10/image.img_.320.high_.jpg\;320\;410\;
X-ALT-DESC;FMTTYPE=text/html:\\n\\n\\n
\\n\\n
PHIND Seminar Series: Top
ic TBA
\n
Christina Curtis\, Ph.D.
\nAssociate Professor of
Medicine (Oncology) and of Genetics
\nStanford University
\n
p>\n
Location: Venue coming soon!
\n11:00am – 12:00pm Seminar & Dis
cussion
\n12:00pm – 12:15pm Reception
\nRSVP coming soon!
\n<
p> \n
ABSTRACT
\nComing soon!
\n
\n<
p>
ABOUT\nComing soon!\n
\n
Hosted
by: Garry Gold\, M.D.
\nSponsored by the PHIND Center and th
e Department of Radiology
\n
END:VEVENT
BEGIN:VEVENT
UID:ai1ec-2913@web.stanford.edu/group/radweb/cgi-bin/radcalendar
DTSTAMP:20240410T061457Z
CATEGORIES;LANGUAGE=en-US:CME\,CME Radiology Grand Rounds\,Radiology
CONTACT:Tricia Hatcliff\; 650-498-7359\; thatcliff@stanford.edu
DESCRIPTION:CME Grand Rounds – Topic: TBD\nJocelyn D. Chertoff\, MD\, MS\nP
rofessor\nRadiology\, Obstetrics & Gynecology\nChair\, Radiology\nDartmout
h Hitchcock Medical Center\n \nJoin from PC\, Mac\, Linux\, iOS or Android
: https://stanford.zoom.us/j/600003703?pwd=RjcwS2MvOG1qVkxyL3U0RmNtUDVWdz0
9\nMeeting ID: 600 003 703\nPassword: 566048\nOr iPhone one-tap (US Toll):
+18333021536\,\,600003703# or +16507249799\,\,600003703#\nOr Telephone:\n
Dial: +1 650 724 9799 (US\, Canada\, Caribbean Toll) or +1 833 302 1536 (U
S\, Canada\, Caribbean Toll Free)\nInternational numbers available: https:
//stanford.zoom.us/u/acuqphnvqT\n \nABSTRACT\nComing soon!\n \nBIO\nComing
soon!
DTSTART;TZID=America/Los_Angeles:20211022T120000
DTEND;TZID=America/Los_Angeles:20211022T130000
LOCATION:Zoom - See Description for Zoom Link
SEQUENCE:0
SUMMARY:CME Grand Rounds – Jocelyn D. Chertoff\, MD\, MS
URL:http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/event/cme-gran
d-rounds-jocelyn-d-chertoff-md-ms/
X-COST-TYPE:free
X-WP-IMAGES-URL:thumbnail\;http://web.stanford.edu/group/radweb/cgi-bin/rad
calendar/wp-content/uploads/2021/07/Chertoff-150x150.jpg\;150\;150\;1\,med
ium\;http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/wp-content/u
ploads/2021/07/Chertoff.jpg\;196\;257\;
X-ALT-DESC;FMTTYPE=text/html:\\n\\n\\n
\\n\\n
CME Grand Rounds – Topic: TBD
\n
Jocelyn D. Chertoff\, MD\, MS
\nProfessor
\nRadiology\
, Obstetrics & Gynecology
\nChair\, Radiology
\nDartmouth Hitchc
ock Medical Center
\n
\n
Join from PC\, Mac\, Linux\, iOS or A
ndroid: https://stanford.zoom.us/j/600003703?pwd=RjcwS2MvOG1qVkx
yL3U0RmNtUDVWdz09
\nMeeting ID: 600 003 703
\nPassword: 5660
48
\nOr iPhone one-tap (US Toll): +18333021536\,\,600003703# or +1650
7249799\,\,600003703#
\nOr Telephone:
\nDial: +1 650 724 9799 (U
S\, Canada\, Caribbean Toll) or +1 833 302 1536 (US\, Canada\, Caribbean T
oll Free)
\nInternational numbers available: https://stanford.zoom.us/u/acuqphnvqT
\n
\n
ABSTRACT
\nComing soon!
\n
\n
BIO
\nComing soon!
\n
END:VEVENT
BEGIN:VEVENT
UID:ai1ec-2521@web.stanford.edu/group/radweb/cgi-bin/radcalendar
DTSTAMP:20240410T061457Z
CATEGORIES;LANGUAGE=en-US:MIPS\,MIPS Seminar
CONTACT:Ashley Williams\; ashleylw@stanford.edu\; https://med.stanford.edu/
mips/events.html
DESCRIPTION:MIPS Seminar Series: Title TBA\nSteven Paul Poplack\, MD\nProfe
ssor of Radiology (Breast Imaging)\nStanford University Medical Center\n
\nLocation: Coming soon!\n12:00pm – 12:45pm Seminar & Discussion\nRSVP: Co
ming soon!\n \nABSTRACT\nComing soon!\n \nABOUT\nComing soon!\n \nHosted b
y: Katherine Ferrara\, PhD\nSponsored by: Molecular Imaging Program at Sta
nford & the Department of Radiology
DTSTART;TZID=America/Los_Angeles:20211028T120000
DTEND;TZID=America/Los_Angeles:20211028T124500
LOCATION:Venue coming soon!
SEQUENCE:0
SUMMARY:MIPS Seminar – Steven Paul Poplack\, MD
URL:http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/event/mips-sem
inar-steven-paul-poplack-md/
X-COST-TYPE:free
X-WP-IMAGES-URL:thumbnail\;http://web.stanford.edu/group/radweb/cgi-bin/rad
calendar/wp-content/uploads/2019/10/steven-poplack-150x150.jpg\;150\;150\;
1\,medium\;http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/wp-con
tent/uploads/2019/10/steven-poplack-300x300.jpg\;300\;300\;1\,large\;http:
//web.stanford.edu/group/radweb/cgi-bin/radcalendar/wp-content/uploads/201
9/10/steven-poplack.jpg\;320\;320\;
X-ALT-DESC;FMTTYPE=text/html:\\n\\n\\n
\\n\\n
MIPS Seminar Series: Title TBA
\n
Steven Paul Poplack\, MD
\nProfessor of Radiology
(Breast Imaging)
\nStanford University Medical Center
\n
\n
Location: Coming soon!
\n
12:00pm – 12:45pm Seminar & Discussion\nRSVP: Coming soon!
\n
\n
ABSTRACT
\n
Coming soon!
\n
\n
ABOUT
\nComing soo
n!
\n
\n
Hosted by: Katherine Ferrara\, PhD
\nSponsored by: Molecular Imaging Program at Stanford & the Department of
Radiology
\n
END:VEVENT
BEGIN:VEVENT
UID:ai1ec-2937@web.stanford.edu/group/radweb/cgi-bin/radcalendar
DTSTAMP:20240410T061457Z
CATEGORIES;LANGUAGE=en-US:CME\,CME Radiology Grand Rounds\,Radiology
CONTACT:Tricia Hatcliff\; 650-498-7359\; thatcliff@stanford.edu
DESCRIPTION:CME Grand Rounds Etta K. Moskowitz Lectureship – Topic: TBD\nEl
izabeth Krupinski\, PhD\nProfessor & Vice Chair for Research\nRadiology &
Imaging Sciences\nEmory University School of Medicine\n \nJoin from PC\, M
ac\, Linux\, iOS or Android: https://stanford.zoom.us/j/600003703?pwd=Rjcw
S2MvOG1qVkxyL3U0RmNtUDVWdz09\nMeeting ID: 600 003 703\nPassword: 566048\nO
r iPhone one-tap (US Toll): +18333021536\,\,600003703# or +16507249799\,\,
600003703#\nOr Telephone:\nDial: +1 650 724 9799 (US\, Canada\, Caribbean
Toll) or +1 833 302 1536 (US\, Canada\, Caribbean Toll Free)\nInternationa
l numbers available: https://stanford.zoom.us/u/acuqphnvqT\n \nABSTRACT\nC
oming soon!\n \nBIO\nComing soon!
DTSTART;TZID=America/Los_Angeles:20211104T173000
DTEND;TZID=America/Los_Angeles:20211104T183000
LOCATION:Zoom - See Description for Zoom Link
SEQUENCE:0
SUMMARY:CME Grand Rounds Etta K. Moskowitz Lectureship – Elizabeth Krupinsk
i\, PhD
URL:http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/event/cme-gran
d-rounds-etta-k-moskowitz-lectureship-elizabeth-krupinski-phd/
X-COST-TYPE:free
X-WP-IMAGES-URL:thumbnail\;http://web.stanford.edu/group/radweb/cgi-bin/rad
calendar/wp-content/uploads/2021/07/Krupinski.jpg\;144\;144\;
X-ALT-DESC;FMTTYPE=text/html:\\n\\n\\n
\\n\\n
CME Grand Rounds Etta K. Moskowitz Lecturesh
ip – Topic: TBD
\n
Elizabeth Krupinski\, PhD
\n
Professor & Vice Chair for Research
\nRadiology & Imaging Sciences
\nEmory University School of Medicine
\n
\n
Join from PC\,
Mac\, Linux\, iOS or Android: https://stanford.zoom.us/j/6000037
03?pwd=RjcwS2MvOG1qVkxyL3U0RmNtUDVWdz09
\nMeeting ID: 600 003 703
\nPassword: 566048
\nOr iPhone one-tap (US Toll): +18333021536\
,\,600003703# or +16507249799\,\,600003703#
\nOr Telephone:
\nDi
al: +1 650 724 9799 (US\, Canada\, Caribbean Toll) or +1 833 302 1536 (US\
, Canada\, Caribbean Toll Free)
\nInternational numbers available: https://stanford.zoom.us/u/a
cuqphnvqT
\n
\n
ABSTRACT
\nComing so
on!
\n
\n
BIO
\nComing soon!
\n
END:VEVENT
BEGIN:VEVENT
UID:ai1ec-2957@web.stanford.edu/group/radweb/cgi-bin/radcalendar
DTSTAMP:20240410T061457Z
CATEGORIES;LANGUAGE=en-US:CME\,CME Radiology Grand Rounds\,Radiology
CONTACT:Tricia Hatcliff\; 650-498-7359\; thatcliff@stanford.edu
DESCRIPTION:CME Grand Rounds – “Promote Your Academic Career Using Social M
edia”\nMichael Gisondi\, MD\nAssociate Professor & Vice Chair of Education
\nEmergency Medicine\nStanford University\n \nJoin from PC\, Mac\, Linux\,
iOS or Android: https://stanford.zoom.us/j/600003703?pwd=RjcwS2MvOG1qVkxy
L3U0RmNtUDVWdz09\nMeeting ID: 600 003 703\nPassword: 566048\nOr iPhone one
-tap (US Toll): +18333021536\,\,600003703# or +16507249799\,\,600003703#\n
Or Telephone:\nDial: +1 650 724 9799 (US\, Canada\, Caribbean Toll) or +1
833 302 1536 (US\, Canada\, Caribbean Toll Free)\nInternational numbers av
ailable: https://stanford.zoom.us/u/acuqphnvqT\n \nABSTRACT\nComing soon!
\n \nBIO\nComing soon!
DTSTART;TZID=America/Los_Angeles:20211112T120000
DTEND;TZID=America/Los_Angeles:20211112T130000
LOCATION:Zoom - See Description for Zoom Link
SEQUENCE:0
SUMMARY:CME Grand Rounds – Michael Gisondi\, MD
URL:http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/event/cme-gran
d-rounds-michael-gisondi-md/
X-COST-TYPE:free
X-WP-IMAGES-URL:thumbnail\;http://web.stanford.edu/group/radweb/cgi-bin/rad
calendar/wp-content/uploads/2021/07/michael-gisondi_profilephoto-150x150.j
pg\;150\;150\;1\,medium\;http://web.stanford.edu/group/radweb/cgi-bin/radc
alendar/wp-content/uploads/2021/07/michael-gisondi_profilephoto-300x300.jp
g\;300\;300\;1\,large\;http://web.stanford.edu/group/radweb/cgi-bin/radcal
endar/wp-content/uploads/2021/07/michael-gisondi_profilephoto.jpg\;350\;35
0\;
X-ALT-DESC;FMTTYPE=text/html:\\n\\n\\n
\\n\\n
CME Grand Rounds
– “Promote Your Academic Career Using Social Media”
\n
Michae
l Gisondi\, MD
\nAssociate Professor & Vice Chair of Educati
on
\nEmergency Medicine
\nStanford University
\n
\n
Join from PC\, Mac\, Linux\, iOS or Android: https://stanford.zo
om.us/j/600003703?pwd=RjcwS2MvOG1qVkxyL3U0RmNtUDVWdz09
\nMeeting
ID: 600 003 703
\nPassword: 566048
\nOr iPhone one-tap (US Toll)
: +18333021536\,\,600003703# or +16507249799\,\,600003703#
\nOr Telep
hone:
\nDial: +1 650 724 9799 (US\, Canada\, Caribbean Toll) or +1 83
3 302 1536 (US\, Canada\, Caribbean Toll Free)
\nInternational number
s available: https://stanf
ord.zoom.us/u/acuqphnvqT
\n
\n
ABSTRACT\nComing soon!
\n
\n
BIO
\nComing so
on!
\n
END:VEVENT
BEGIN:VEVENT
UID:ai1ec-1703@web.stanford.edu/group/radweb/cgi-bin/radcalendar
DTSTAMP:20240410T061457Z
CATEGORIES;LANGUAGE=en-US:PHIND\,PHIND Seminar Series
CONTACT:Ashley Williams\; ashleylw@stanford.edu
DESCRIPTION:PHIND Seminar Series: Male Infertility and the Future Risk of V
ascular and CV Disease\nMichael Eisenberg\, M.D.\nAssociate Professor of U
rology and\, by courtesy\, of Obstetrics and Gynecology\nStanford Universi
ty Medical Center\n \nGary M. Shaw\, Ph.D.\nNICU Nurses Professor and Prof
essor\, by courtesy\, of Health Research and Policy (Epidemiology) and of
Obstetrics and Gynecology (Maternal Fetal Medicine)\nStanford University\n
\nLocation: Venue coming soon!\n11:00am – 12:00pm Seminar & Discussion\n1
2:00pm – 12:15pm Reception\nRSVP coming soon!\n \nABSTRACT\nComing soon!\n
\nABOUT\nComing soon!\n \nHosted by: Garry Gold\, M.D.\nSponsored by the
PHIND Center and the Department of Radiology
DTSTART;TZID=America/Los_Angeles:20211116T110000
DTEND;TZID=America/Los_Angeles:20211116T120000
LOCATION:Venue coming soon!
SEQUENCE:0
SUMMARY:PHIND Seminar – Michael Eisenberg\, M.D. & Gary M. Shaw\, Ph.D.
URL:http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/event/phind-se
minar-michael-eisenberg-m-d-gary-m-shaw-ph-d/
X-COST-TYPE:free
X-WP-IMAGES-URL:thumbnail\;http://web.stanford.edu/group/radweb/cgi-bin/rad
calendar/wp-content/uploads/2019/10/2020.11_SpeakerMashUp-01-150x150.png\;
150\;150\;1\,medium\;http://web.stanford.edu/group/radweb/cgi-bin/radcalen
dar/wp-content/uploads/2019/10/2020.11_SpeakerMashUp-01-300x150.png\;300\;
150\;1\,large\;http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/wp
-content/uploads/2019/10/2020.11_SpeakerMashUp-01-1024x513.png\;640\;321\;
1\,full\;http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/wp-conte
nt/uploads/2019/10/2020.11_SpeakerMashUp-01.png\;1050\;526\;
X-ALT-DESC;FMTTYPE=text/html:\\n\\n\\n
\\n\\n
PHIND Seminar Series:
Male Infertility and the Future Risk of Vascular and CV Disease
\n
<
a href='https://profiles.stanford.edu/michael-eisenberg'>Michael E
isenberg\, M.D.
\nAssociate Professor of Urology and\, b
y courtesy\, of Obstetrics and Gynecology
\nStanford University Medic
al Center
\n
\n
Gary M. Shaw\, Ph.D.
\nNICU Nurses Professor
and Professor\, by courtesy\, of Health Research and Policy (Epidemiology
) and of Obstetrics and Gynecology (Maternal Fetal Medicine)
\nStanfo
rd University
\n
\n
Location: Venue coming soon!
\n11:00a
m – 12:00pm Seminar & Discussion
\n12:00pm – 12:15pm Reception
\nRSVP coming soon!
\n
\n
ABSTRACT
\nCom
ing soon!
\n
\n
ABOUT
\nComing soon!
\n
\n
Hosted by: Garry Gold\, M.D.
\nSponsored
by the PHIND Center and the Department of Radiology
\n
END:VEVENT
BEGIN:VEVENT
UID:ai1ec-2547@web.stanford.edu/group/radweb/cgi-bin/radcalendar
DTSTAMP:20240410T061457Z
CATEGORIES;LANGUAGE=en-US:MIPS\,MIPS Seminar
CONTACT:Ashley Williams\; ashleylw@stanford.edu\; https://med.stanford.edu/
mips/events.html
DESCRIPTION:MIPS Seminar Series: Title TBA\nMatthew Bogyo\, PhD\nProfessor
of Pathology and of Microbiology and Immunology and\, by courtesy\, of Che
mical and Systems Biology\nStanford University\n \nLocation: Coming soon!
\n12:00pm – 12:45pm Seminar & Discussion\nRSVP: Coming soon!\n \nABSTRACT
\nComing soon!\n \nABOUT\nDr. Bogyo received a B.Sc. degree in Chemistry f
rom Bates College in 1993 and a Ph.D. in Biochemistry from the Massachuset
ts Institute of Technology in 1997. After completion of his degree he was
appointed as a Faculty Fellow in the Department of Biochemistry and Biophy
sics at the University of California\, San Francisco. Dr. Bogyo served as
the Head of Chemical Proteomics at Celera Genomics from 2001 to 2003 while
maintaining an Adjunct Faculty appointment at UCSF. In the Summer of 2003
Dr. Bogyo joined the Department of Pathology at Stanford Medical School a
nd was appointed as a faculty member in the Department of Microbiology and
Immunology in 2004. His interests are focused on the use of chemistry to
study the role of proteases in human disease. In particular his laboratory
is currently working on understanding the role of cysteine proteases in t
umorgenesis and also in the life cycle of human parasites and bacterial pa
thogens. Dr. Bogyo currently serves on the Editorial Board of Biochemical
Journal\, Cell Chemical Biology\, Molecular and Cellular Proteomics and is
an Academic Editor at PLoS One. Dr. Bogyo is a consultant for several bio
technology and pharmaceutical companies in the Bay Area and is a founder a
nd board member of Akrotome Imaging and Facile Therapeutics.\n \nHosted by
: Katherine Ferrara\, PhD\nSponsored by: Molecular Imaging Program at Stan
ford & the Department of Radiology
DTSTART;TZID=America/Los_Angeles:20211118T120000
DTEND;TZID=America/Los_Angeles:20211118T124500
LOCATION:Venue coming soon!
SEQUENCE:0
SUMMARY:MIPS Seminar – Matthew Bogyo\, PhD
URL:http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/event/mips-sem
inar-matthew-bogyo-phd/
X-COST-TYPE:free
X-WP-IMAGES-URL:thumbnail\;http://web.stanford.edu/group/radweb/cgi-bin/rad
calendar/wp-content/uploads/2019/10/BogyoHeadshotJuly2017-150x150.jpg\;150
\;150\;1\,medium\;http://web.stanford.edu/group/radweb/cgi-bin/radcalendar
/wp-content/uploads/2019/10/BogyoHeadshotJuly2017-244x300.jpg\;244\;300\;1
\,large\;http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/wp-conte
nt/uploads/2019/10/BogyoHeadshotJuly2017.jpg\;320\;393\;
X-ALT-DESC;FMTTYPE=text/html:\\n\\n\\n
\\n\\n
MIPS Seminar Ser
ies: Title TBA
\n
Matthew Bogyo\, PhD
\nProfessor of Pathology and of M
icrobiology and Immunology and\, by courtesy\, of Chemical and Systems Bio
logy
\nStanford University
\n
\n
Location: Coming soon!
p>\n
12:00pm – 12:45pm Seminar & Discussion
\nRSVP: Coming soon!
\n
\n
ABSTRACT
\n
Coming soon!
\n
p>\n
ABOUT
\nDr. Bogyo received a B.Sc. degree in
Chemistry from Bates College in 1993 and a Ph.D. in Biochemistry from the
Massachusetts Institute of Technology in 1997. After completion of his deg
ree he was appointed as a Faculty Fellow in the Department of Biochemistry
and Biophysics at the University of California\, San Francisco. Dr. Bogyo
served as the Head of Chemical Proteomics at Celera Genomics from 2001 to
2003 while maintaining an Adjunct Faculty appointment at UCSF. In the Sum
mer of 2003 Dr. Bogyo joined the Department of Pathology at Stanford Medic
al School and was appointed as a faculty member in the Department of Micro
biology and Immunology in 2004. His interests are focused on the use of ch
emistry to study the role of proteases in human disease. In particular his
laboratory is currently working on understanding the role of cysteine pro
teases in tumorgenesis and also in the life cycle of human parasites and b
acterial pathogens. Dr. Bogyo currently serves on the Editorial Board of B
iochemical Journal\, Cell Chemical Biology\, Molecular and Cellular Proteo
mics and is an Academic Editor at PLoS One. Dr. Bogyo is a consultant for
several biotechnology and pharmaceutical companies in the Bay Area and is
a founder and board member of Akrotome Imaging and Facile Therapeutics.
\n
\n
Hosted by: Katherine Ferrara\, PhD
\nSpo
nsored by: Molecular Imaging Program at Stanford & the Department of Radio
logy
\n
END:VEVENT
BEGIN:VEVENT
UID:ai1ec-3174@web.stanford.edu/group/radweb/cgi-bin/radcalendar
DTSTAMP:20240410T061457Z
CATEGORIES;LANGUAGE=en-US:AIMI\,IBIIS\,IBIIS Seminar Series
CONTACT:Ramzi Totah\; 6507214161\; rtotah@stanford.edu\; https://ibiis.stan
ford.edu/events/seminars/2024seminars.html
DESCRIPTION:Roxana Daneshjou\, MD\, PhD\nAssistant Professor\, Biomedical D
ata Science & Dermatology\nAssistant Director\, Center of Excellence for P
recision Heath & Pharmacogenomics\nDirector of Informatics\, Stanford Skin
Innovation and Interventional Research Group\nStanford University\nTitle:
Building Fair and Trustworthy AI for Healthcare\n\n\n\n\n\n\n\n\n\nAbstra
ct: AI for healthcare has the potential to revolutionize how we practice m
edicine. However\, to do this in a fair and trustworthy manner requires sp
ecial attention to how AI models work and their potential biases. In this
talk\, I will cover the considerations for building AI systems that improv
e healthcare.
DTSTART;TZID=America/Los_Angeles:20240417T120000
DTEND;TZID=America/Los_Angeles:20240417T130000
LOCATION:Clark Center S360 - Zoom Details on IBIIS website @ 318 Campus Dri
ve
SEQUENCE:0
SUMMARY:IBIIS & AIMI Seminar: Building Fair and Trustworthy AI for Healthca
re
URL:http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/event/ibiis-ai
mi-seminar-building-fair-and-trustworthy-ai-for-healthcare/
X-COST-TYPE:free
X-WP-IMAGES-URL:thumbnail\;http://web.stanford.edu/group/radweb/cgi-bin/rad
calendar/wp-content/uploads/2024/04/Roxana.jpg\;200\;200\,medium\;http://w
eb.stanford.edu/group/radweb/cgi-bin/radcalendar/wp-content/uploads/2024/0
4/Roxana.jpg\;200\;200\,large\;http://web.stanford.edu/group/radweb/cgi-bi
n/radcalendar/wp-content/uploads/2024/04/Roxana.jpg\;200\;200\,full\;http:
//web.stanford.edu/group/radweb/cgi-bin/radcalendar/wp-content/uploads/202
4/04/Roxana.jpg\;200\;200
X-ALT-DESC;FMTTYPE=text/html:\\n\\n\\n
\\n\\n
\n
\n
\n
\n
Roxana Daneshjou\, MD\, PhD
\nAssistant Professor\, Biomedical Data Science & Dermatology
\nAssistant Director\, Center of Excellence for Precision Heath & Pharmaco
genomics
\nDirector of Informatics\, Stanford Skin Innovation and Int
erventional Research Group
\nStanford University
\n
Title
: Building Fair and Trustworthy AI for Healthcare
\n
\n
\n\n
\n
\n
\n
\n\n
\n
Abstract: AI for healthcare has t
he potential to revolutionize how we practice medicine. However\, to do th
is in a fair and trustworthy manner requires special attention to how AI m
odels work and their potential biases. In this talk\, I will cover the con
siderations for building AI systems that improve healthcare.
\n
\n
\n\n
\n
\n
\n
END:VEVENT
END:VCALENDAR